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The genus of Cronobacter spp. is an emerging opportunistic food borne pathogen, causing 
rare but serious infections of bacteraemia, meningitis and necrotizing enterocolitis in infants 
(Anonymous, 2006a; Anonymous, 2007b; Mullane et al., 2007). Contaminated powered 
infant formula (PIF) has been implicated as a most likely source of transmission of 
Cronobacter spp.. A microbiological association between consumption of PIF contaminated 
during manufacture and/or mishandling when reconstituted and a number of clinical 
outbreaks has been established (Van Acker et al., 2001). Understanding of biochemical 
characteristics and growth profiles of Cronobacter spp. is therefore essential for the 
investigation of inhibitive strategies against the growth of Cronobacter spp. as well as for 
the development of detection and identification methods of Cronobacter spp. in 
reconstituted PIF. 
 
1.1 Taxonomy 
Cronobacter spp. are a group of gram-negative, motile, non-spore forming, facultative 
anaerobic bacteria. These organisms were originally referred to as “yellow-pigmented 
Enterobacter cloacae” until they were classified as a new species, Enterobacter sakazakii, 
within the genus Enterobacter (Farmer et al., 1980). In year 2007 and 2008, a further 
classification of E. sakazakii with the creation of a new genus, Cronobacter, has been 
proposed. The genus Cronobacter consists of six species: C. sakazakii, C. malonaticus, C. 
turicensis, C. muytjensii, C. genomospecies 1 and C. dublinensis which contains three 
subspecies dublinensis, lactaridi and lausannensis (Iversen et al., 2007; Iversen et al., 2008). 
This genus proposal was based on data from a polyphasic taxonomic study of an extensive 
collection of target strains in which full-length 16S rRNA sequencing, fluorescent-labelled 
Amplified Fragment Length Polymorphism (f-AFLP) fingerprinting, ribotyping, DNA-DNA 
hybridization and characterization of phenotypic profiles were applied. Recently Joseph et al. 
(2012) used 16S rRNA sequencing and a Multilocus Sequence Analysis (MLSA) of seven 
housekeeping genes to re-evaluate the diversity of the genus. Based on his data, a new 
species C. condimenti was identified and the original C. genomospecies 1 was replaced by C. 
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universalis. Cronobacter genus comprises currently seven species: C. sakazakii, C. 
malonaticus, C. turicensis, C. muytjensii, C. dublinensis, C. condimenti and C. universalis. 
 
1.2  Biochemical Characteristics of Cronobacter  
Farmer et al. (1980) found that Cronobacter spp. (previously E. sakazakii) possessed 
biochemical reactions very similar to those of E. cloacae but Cronobacter spp. were 
D-sorbitol negative and produced yellow-pigmented colonies on Tryptic Soy Agar (TSA) at 
25°C after 48 h. An additional distinguishing property for Cronobacter spp. is the Tween 80 
esterase activity, which was positive in 97.3% of isolates (Aldova et al., 1983). Muytjens et 
al. (1984) investigated the enzymatic profiles of 129 Cronobacter spp. strains and 97 
Enterobacter strains including E. cloacae, E. aerogenes and E. agglomerans and determined 
the presence of α-glucosidase as a major difference between Cronobacter spp. and other 
Enterobacter species. 
 
1.3 Epidemiology and Pathogenicity 
Cronobacter spp. are considered as emerging opportunistic pathogens and have been 
identified as causes of bacteraemia, necrotizing enterocolitis and neonatal meningitis 
(Arseni et al., 1987; Bar-Oz et al., 2001; Giovannini et al., 2008; Mullane et al., 2007). 
Urmenyi and Franklin (1961) recorded the first isolation of Cronobacter spp. from a case of 
neonatal meningitis. Surveillance data of the Food and Agriculture Organization of the 
United Nations and World Health Organization (FAO/WHO) (Anonymous, 2008b) showed 
that since 1961 and up to 2008, approximately 120 documented cases of Cronobacter 
infections in infants and young children less than three years of age have been reported 
worldwide with at least 27 associated deaths, showing an average case-fatality rate of 22%. 
This leads to the International Commission on Microbiological Specification for Foods 
(ICMSF) (Anonymous, 2002a) ranking Cronobacter spp. as “Severe hazard for restricted 
populations, life threatening or substantial chronic sequelae or long duration.” An annual 
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incidence rate for Cronobacter invasive infections has been estimated to be 1 per 100,000 
infants, whereas higher annual incidence rates among the low birth weight infants (< 2500 g) 
and very low birth weight infants (< 1500 g) of 8.7 and 9.4 per 100,000 infants respectively 
were reported (Anonymous, 2006a). The case-mortality rate caused by Cronobacter 
infection has been reported to be higher (50%) among premature or (very) low birth weight 
infants than full-term or infants with birth weight ≥ 2500 g (30%) (Lai, 2001). Although 
Cronobacter has caused diseases in all age groups, neonates under 28 days, particularly 
preterm-infants, low birth weight infants, immunocompromised or medically debilitated 
infants as well as infants with HIV-positive mothers are thought to be at the greatest risk for 
severe infection (Anonymous, 2007b). It has been concluded that infants during the first few 
weeks of life are particularly susceptible to meningitis rather than bacteraemia if exposed to 
Cronobacter. Data from 45 clinical cases have revealed that bacteraemia appears to occur at 
a later median age of 35 days of life in premature infants, whereas meningitis cases have 
been more frequently observed among full-term infants who generally develop symptoms 
before the age of one week. Infant with bacteraemia tend to fare better with a mortality of 
10%. Conversely 44% of those with meningitis died and the majority of survivors 
experienced long-term neurological consequences (Anonymous, 2006a). 
 
The mechanism of pathogenicity and potential virulence factors of Cronobacter remain 
elusive. Pagotte et al. (2003) were the first to investigate the virulence factor in Cronobacter 
spp. using a suckling mouse model and found four out of 18 Cronobacter strains producing 
enterotoxin. Townsend et al. (2007) reported that Cronobacter strains persisted or replicated 
in macrophages and showed attachment and invasion of human endothelial cells to different 
extents, indicating a diversity of virulence among Cronobacter isolates. However its 
relevance to human infant infections has yet to be established. To date only strains of C. 
sakazakii, C. malonaticus and C. turicensis have been found to be associated with reported 
neonatal infections. Particularly a variety of C. sakazakii with sequence type ST4 causes 
more infant meningitis (Joseph and Forsythe, 2011). Despite the inter- and intra-species 
variation in virulence, no data currently show that any of the Cronobacter species does not 
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pose a risk to neonatal and infant health. Therefore, all species in the genus Cronobacter are 
considered to be pathogenic (Anonymous, 2008b). In the investigation performed by Pagotte 
et al. (2003), a lethal dose of 10
8
 CFU on infant mouse by intraperitoneal injection has been 
concluded for all the 18 Cronobacter strains, whereas only two isolates caused death when 
given orally, however, this value does not necessarily reflect the dose-response in human 
neonates. Till now no evident data for an infectious dose associated with Cronobacter spp. is 
available. An infectious dose of 1000 CFU similar to that of Neisseria meningitidis and E. 
coli O157 has been proposed by Iversen and Forsythe (2003). The FAO/WHO (Anonymous, 
2007b) estimated a linear dose-response relationship at low dose below 10,000 CFU. 
 
1.4 Production of Powdered Infant Formula, 
Contamination Routes and Prevalence of Cronobacter in 
Powdered Infant Formula 
It has been internationally recognized that breast milk is the best source of nutrition to 
infants and young children. There are, however, occasions when breast milk is not available 
or where the mother is unable to breastfeed. In such cases, powdered formulae which are 
formulated to meet the special nutritional needs of infants represent one of the dietary 
options to replace the breast milk partially or totally (Anonymous, 2007c). Codex 
Alimentarius Commission (CAC) has divided powdered formulae into powdered infant 
formula (PIF), follow-up formula (FUF), human milk fortifiers and formula for special 
medical purposes. PIF is defined as a breast milk substitute specially manufactured to satisfy 
the nutritional requirements of infants as sole source of nutrition during the first months of 
life to the introduction of appropriate complementary feeding. FUF is defined as a food 
intended for use as a liquid part of the weaning diet for the infant from the 6
th
 month on and 
for young children (Anonymous, 2008a). 
 
PIF can be manufactured in a wet-mix process, a dry-blending process or a combined 
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process (Cordier, 2008). In the wet-mix process, all unprocessed raw materials as well as 
separately processed ingredients are handled in a liquid form, heat treated, dried and brought 
to the filling stage. The dry-mix procedure involves dry mixing of heat sensitive ingredients 
like vitamins, minerals, starch and carbohydrates into the powder after spray-drying. In the 
mix-process, the unprocessed raw materials and ingredients are processed in a liquid phase 
to obtain a base powder and other ingredients are added into the base powder and further 
blended. Due to the limitations of current technology, it is not possible to produce sterile PIF 
at a feasible price. PIF can be contaminated with low levels of pathogens e.g. Cronobacter 
spp. via intrinsic and extrinsic routes. Intrinsic contamination of PIF during the 
manufacturing process after pasteurization can occur either via addition of thermally 
sensitive plant-derived ingredients (e.g. vitamins, starch, protein and lecithin) or via 
transmission of materials in the processing environment such as aerosol, dust and water 
droplet (Iversen et al., 2009; Mullane et al., 2008). It is notable that although the standard 
pasteurization practices (71.6°C, 15 s or 74.4°C, 25 s) are sufficient to inactive Cronobacter 
spp, the organism may survive the spray drying (Arku et al., 2008). An extrinsic 
contamination of PIF can occur during the preparation and feeding when contaminated 
utensils such as spoons, blenders, bottles, teats are used (Bar-Oz et al., 2001; Simmons et al., 
1989).  
 
Being a ubiquitous organism, Cronobacter spp. have been isolated from a wide variety of 
food, environmental and clinical sources (Cottyn et al., 2001; Farber, 2004; Gallagher and 
Ball, 1991; Gassem, 1999; Kandhai et al., 2004; Leclercq et al., 2002). The presence of 
Cronobacter in PIF is of particular concern. A clear epidemiological correlation between 
Cronobacter infections in infants and the consumption of contaminated PIF has been 
described (Biering et al., 1989; Clark et al., 1990). Together with Salmonella, Cronobacter 
spp. have been categorized as “A” organisms. PIF contaminated with “A” organisms has 
been both epidemiologically and microbiologically shown to be the source and vehicle of 
infection in infants (Anonymous, 2007b). Several studies have investigated the prevalence 
of Cronobacter spp. in PIF and other infant foods. Muytjens et al. (1988) examined 141 
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different breast milk substitute powders from 35 countries and determined a contamination 
level of Cronobacter ranging from 0.36 to 66 CFU per 100 g. In a survey of 120 cans of 
Canadian infant formula samples, the prevalence of Cronobacter was 6.7%, with a 
contamination level of 0.36 CFU per 100 g (Nazarowec-White and Farber, 1997a). In a 
British survey, two samples (2.4%) were positive for Cronobacter among 82 PIF products 
purchased from retails (Iversen and Forsythe, 2004). Jongenburger et al. (2011) investigated 
2291 samples of 1 g from a recalled batch and found a sporadic presence of Cronobacter 
cells in eight samples, with the two largest clusters containing 123 and 560 cells 
respectively.  
 
1.5 Methodology 
1.5.1 Conventional Microbiological Isolation of Cronobacter  
1.5.1.1 Culture-based Isolation 
The conventional culture–based procedure for detection of micro-organisms in foods 
comprises three basic steps: The first step is pre-enrichment in a non-selective medium 
which enables recovery of sub-lethally injured cells. The second step is selective enrichment 
containing compounds which promote the growth of the target micro-organisms to be 
isolated but are inhibitory to the majority of the background micro-organisms. The third step 
is streaking the selective broth onto selective solid media. In case of presumptive colonies 
on the agar, a confirmation step will be carried out.  
 
The initial method for isolation and detection of Cronobacter from PIF applied by Muytjens 
et al. (1988) and Nazarowec-White and Farber (1997a) comprised 1) pre-enrichment in 
Buffered Peptone Water (BPW), 2) enrichment in Enterobacteriaceae Enrichment (EE) broth, 
3) streaking onto Violet Red Bile Glucose (VRBG) agar, 4) picking five Enterobacteriaceae 
colonies on TSA agar and incubation at 25°C for 48-72h, 5) confirmation of 
yellow-pigmented colonies on TSA with API 20E (bioMérieux, France). This method was 
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adopted by the U.S. Food and Drug Administration (FDA) with modification of 
pre-enrichment in distilled water (Anonymous, 2002b). Being a time-consuming procedure, 
the FDA method requires a minimum of 5 days to finish. Also no selective pre-enrichment 
and enrichment broths were involved in this method. It is likely that Cronobacter spp. are 
outgrown by background Enterobacteriaceae, leading to few Cronobacter colonies isolated 
on VRGB and a subsequently reduced chance of picking the target organisms onto TSA. In 
contrast the European Community (EC) regulation refers to International Standards 
Organization (ISO) standard method ISO/TS 22964 which consists of pre-enrichment in 
BPW, followed by selective enrichment in modified lauryl sulphate tryptose (mLST) broth 
with vancomycin, plating on selective differential media and biochemical characterization of 
typical colonies (Anonymous, 2006b). 
 
1.5.1.2 Chromogenic and Fluorogenic Media for Cronobacter Differentiation 
Several media have been developed for a specific detection of Cronobacter from PIF. All of 
these selective media take advantage of the biochemical characteristic, the α-glucosidase 
activity of Cronobacter which was first described by Muytjens et al. (1988).  
 
A differential selective medium, OK medium, described by Oh and Kang (2004) used a 
fluorogenic substrate, 4-methyl-umbelliferyl-α-D-glucopyranoside with the fluorogen 
serving as indicator to detect α-glucosidase activity. Druggan-Forsythe-Iversen (DFI) agar 
contains the chromogenic substrate 5-bromo-4-chloro-3-indolyl-α-D-glucopyranoside 
(Iversen et al., 2004a). Being hydrolysed by α-glucosidase positive organism, 
bromo-choloro-indigo will be liberated from the substrate and typical blue-green colonies 
will be produced. In addition, sodium thiosulphate and ammonium iron citrate were 
incorporated in the DFI agar as hydrogen sulphide indicator to differentiate Cronobacter 
from H2S positive organisms like Proteus and Salmonella which appear black on the agar.  
 
The Enterobacter sakazakii isolation agar (ESIA) recommended in the ISO method has been 
commercially available by AES Chemunex France since 2005 and it is based on the same 
chromogenic agent as DFI agar. Restaino et al. (2006) described the R&F Enterobacter 
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sakazakii chromogenic plating medium (ESPM) which contains three sugars (sorbitol, 
D-arabitol and adonitol) as well as two chromogens (X-α-D-glucopyranoside and 
X-α-D-cellobioside), causing Cronobacter colonies to create blue-black or blue-grey 
colonies on medium.   
 
1.5.1.3 Other Culture Method: Impedance method 
The impedance method is an alternative to the conventional microbiological methods. The 
term impedance refers to the electrical resistance that occurs in the alternating current circuit. 
Due to the microbial metabolism in the liquid culture medium, large molecules are broken 
down into smaller, electrically charged molecules. These changes in the molecular 
composition increase the conductivity of liquid nutrients and lower their electrical resistance. 
With the first application in clinical microbiology in 1975 (Wheeler and Goldschmidt, 1975), 
the technology has been widely used as a standardized rapid method in food microbiology in 
quality control laboratories in food industry, being recognized by numbers of official 
methods collections such as Association Française de Normalisation (AFNOR) (Anonymous, 
2010a, 2010b) and Deutsche Industrie Norm (DIN NORM) (Anonymous, 1999, 2001, 2005). 
For detection and enumeration of several food relevant micro-organisms such as lactobacilli, 
E. coli, Clostridia and Salmonella, the impedance measurement has been assessed as a valid 
method (Colquhoun et al., 1995; Dromigny et al., 1997; Joosten et al., 1994; Lanzanova et 
al., 1993). To date the impedance technology has been optimized in its specificity for food 
relevant bacteria by the development of impedance specific media and the combination of 
impedance detection with immunological and molecular biological confirmation methods.  
1.5.2 Identification of Cronobacter  
1.5.2.1 Phenotypic Methods: Biochemical Identification Kits 
Traditional phenotypic identification is based upon biochemical pathway and carbon source 
utilization. For confirmation of presumptive Cronobacter spp. isolated from agars, various 
commercially available biochemical systems, including API 20E, ID 32E, VITEK 2 
(bioMérieux, France) and Biolog GN2 (Biolog, USA) have been used. Iversen et al. (2006) 
CHAPTER 1 
 
10 
 
investigated the original 15 biotypes described by Farmer et al. (1980) in correlation with 
four clusters formed in 16S rRNA sequences and established a new biogroup 16. As 
indicated by Iversen et al. (2007), five Cronobacter species C. sakazakii, C. malonaticus, C. 
muytjensii, C. dublinenesis and C. turicensis can be distinguished using four key 
biochemical reactions indole, dulcitol, malonate and methyl-α-D-glucoside. 
 
16 biogroups are distributed among Cronobacter species as following: 
 Cronobacter sakazakii sp. nov.    (Biogroup 1-4, 7, 8, 11 and 13) 
 Cronobacter malonaticus sp. nov.    (Biogroup 5, 9, 14) 
 Cronobacter dublinensis subsp.    (Biogroup 12) 
 dublinensis subsp. nov. 
Cronobacter dublinensis subsp.    (Biogroup 10) 
 lausannensis subsp. nov. 
Cronobacter dublinensis subsp.    (Biogroup 6) 
 lactaridi subsp. nov. 
 Cronobacter muytjensii sp. nov.    (Biogroup 15) 
 Cronobacter turicensis sp. nov.    (Biogroup 16) 
Two strains belonging to Cronobacter universalis (formerly Cronobacter genomospecies 1) 
have not been associated with any specific biogroup. 
 
1.5.2.2 Genotypic Methods 
1.5.2.2.1 Polymerase Chain Reaction (PCR) 
To date several conventional and real time Polymerase Chain Reaction (PCR)-based systems 
that enable sensitive, specific and rapid end detection of Cronobacter from PIF, enrichment 
broths and media have been described. Targets for conventional PCR assays include e.g. the 
16S rRNA gene (Hassan et al., 2007; Lehner et al., 2004), 1,6 α-gulcosidase gene (gluA) 
(Lehner et al., 2006b), outer membrane protein A (ompA) gene (Mohan Nair and 
Venkitanarayanan, 2006) and a gene encoding a zinc-containing metalloprotease (zpx) 
(Kothary et al., 2007). Seo and Brackett (2005) developed a quantitative real time PCR 
assay for Cronobacter detection targeting an internal segment of the dnaG gene within the 
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macromolecular synthesis operon. Liu et al. (2006) evaluated a real time PCR method based 
on the amplification of an internal transcribed spacer sequence of the 16S–23S rDNA, using 
a Taqman probe and SYBR Green simultaneously.  
 
1.5.2.2.2 Fluoreszenz in situ Hybridization (FISH) 
Fluorescence in situ hybridization (FISH) is an alternative to the DNA-targeted PCR-based 
approaches for rapid bacterial detection. FISH has been widely used for microbial 
identification in medical diagnoses (Kempf et al., 2005; Russmann et al., 2001) and has also 
allowed a rapid detection and identification of organisms including Enterobacteriaceae, and 
Pseudomonas in drink water and food (Baudart et al., 2005; Kitaguchi et al., 2005). Based 
on the binding of fluorescently labelled single-stranded DNA-probes to specific regions on 
the ribosomal RNA of the bacteria, the FISH system detects only living cells (Amann et al., 
1995; DeLong et al., 1989). Using the commercially available test system based on FISH, 
the VIT
®
 kit (Vermicon Identification Technology, Germany), presumptive Cronobacter 
isolates have been identified with 100% accuracy (Lehner et al., 2006a). The same test kit 
has been applied in the investigation of Sanjaq (2008), showing no false negative or false 
positive results in differentiating 101 Cronobacter isolates from 7 other Enterobacteriaceae 
species. 
 
1.5.2.2.3 16S rRNA gene sequencing  
Much effort has been put on the development of genotypic tools for Cronobacter 
identification with a high discrimination power to the species and subspecies level. The 16S 
rRNA gene is by far the most common housekeeping genetic marker because the ribosomal 
small subunit is present universally among bacteria and it includes both hypervariable 
regions with species-specific variability where sequences have diverged over evolution and 
strongly conserved regions, which makes the 16S rRNA gene sequencing a highly useful 
tool to study bacterial phylogeny, ecology and taxonomy (Janda and Abbott, 2007; Weisburg 
et al., 1991). Genomic DNA is extracted, amplified with universal 16S rRNA primer and 
sequenced. The cycle sequencing reaction is a modification of the traditional Sanger method 
using base-specific, dideoxynucleotide-terminated chain elongation method with 
modification for the use of reverse transcriptase and RNA template (Lane et al., 1985; 
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Sanger et al., 1977). By comparing sequence data in gene databases in public or private 
domains, it is possible to analyse relationships between various organisms and to identify 
unknown micro-organisms. This molecular approach has been extensively used for 
identification and classification of environmental and clinical bacterial isolates (Clarridge, 
2004; Drancourt et al., 2000; Vandamme et al., 1996). Using 16S rRNA gene sequencing, 
the type strain of Cronobacter was found to be closer to Citrobacter (C.) koseri (97.8% 
similar) than to E. cloacae (97%) although the latter has been found to share most 
phenotypic features with Cronobacter (Iversen et al., 2004c). Four phylogenetic clusters 
have been defined among 189 Cronobacter strains analysed with partial 16S rRNA gene 
sequencing and this helped to form the basis of the taxonomic re-classification of these 
organisms (Iversen et al., 2006). 
 
1.5.2.2.4 Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass 
Spectrometry (MALDI-TOF MS) 
Currently, matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF MS) has been introduced as a new method for phylogenetic classification and 
identification of bacteria on the basis of protein profiling. The concept of bacterial 
differentiation/identification by detection of protein mass patterns is based on the principle 
that genomic sequences of organisms coding for production of proteins are determinant for 
phylogenetic differences between organisms. Since proteins reflect the genomic differences, 
the mass spectra should be able to serve as a differentiation/classification vector for bacteria 
(Holland et al., 1996; Krishnamurthy and Ross, 1996; Krishnamurthy et al., 1996). Each 
mass spectrometer is composed of three units: an ion source to generate ion and transfer the 
analyte ions into the gas phase; a mass analyzer to separate ions by the mass-to charge ratio 
(m/z) and a detector for ion monitoring. In practice, bacterial samples are first subjected to a 
protein extraction method, embedded in small acidic molecules known as matrix such as 
α-cyano-4-hydroxycinnamic acid which desorbs laser energy and analyzed by mass 
spectrometry (Freiwald and Sauer, 2009). As a large majority of the bacterial proteins 
detected by this approach are of ribosomal origin, the generated masses of these ribosomal 
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proteins represent a specific fingerprint which can be used for phylogenetic classification 
and identification of bacteria. Based on comparison of protein biomarkers with high 
reproducibility and whole specific spectral fingerprints of protein peak patterns, 
MALDI-TOF MS identification system has been validated for foodborne pathogens such as 
Campylobacter, Clostridia, Cronobacter, Salmonella and Listeria (Alispahic et al., 2010; 
Barbuddhe et al., 2008; Dieckmann et al., 2008; Grosse-Herrenthey et al., 2008; Stephan et 
al., 2010). 
 
1.6 Growth of Cronobacter in Reconstituted PIF 
Previous work by Nazarowec-White and Farber (1997a) showed that the growth temperature 
of eleven Cronobacter strains in Brain Heart Infusion (BHI) ranged from 5.5°C to 45°C. 
Iversen et al. (2004b) reported that the organism grew in reconstituted PIF from 6°C to 47°C, 
optimally at 37°C-43°C. According to Nazarowec-White and Farber (1997a), average 
generation times of Cronobacter strains were 40 min at room temperature of 23°C and 4.98 
h at 10°C in three different formulae. Iversen et al. (2004b) found the mean generation times 
of six Cronobacter strains in reconstituted PIF were 13.7 h, 1.7 h and 22 min at 6°C, 21°C 
and 37°C. Lag times of Cronobacter spp. reported by Nazarowec-White and Farber (1997a) 
ranged from 9 to 47 h at 10°C and from 2 to 3 h at 23°C respectively. Lag times have been 
estimated to be 83 h at 10°C and 1.7 h at 37°C in average (Kandhai et al., 2006). Based on a 
low contamination level of 0.36 Cronobacter cells/100 g PIF reported by Muytjens et al. 
(1988) and a single feeding of 18 g PIF, an infectious dose of 1000 Cronobacter cells would 
be achieved in 9 days at 8°C, 7.9 days at 10°C, 17.9 h at 21°C and 7 h at 37°C, without 
taking into account possible inactivation of Cronobacter cells during PIF preparation, 
bacterial proliferation in infant stomach or cumulative exposure due to 4-6 feeding of infants 
in a 24 h period (Iversen and Forsythe, 2003). From the data shown in this theoretical 
calculation model, it is evident that reconstituted PIF contaminated with low levels of 
Cronobacter is unlikely to cause an infection in a healthy baby unless inappropriate 
preparation, handling and storage of feeding bottle including e.g. gross temperature abuse or 
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extrinsic contamination through poor hygiene preparation exist. The FAO/WHO established 
a quantitative risk assessment model for Cronobacter in PIF and concluded reconstitution 
temperatures of 40°C and 50°C, extended holding time at room temperature and long 
feeding periods as determining factors regarding enhanced risk of Cronobacter infection 
(Anonymous, 2006a). Therefore any control strategy with bacteriostatic or bacteriocidal 
properties in reconstituted PIF are believed to be capable of minimizing the infection risk. 
Heat treatment of food just prior to consumption has long been used as a primary tool to 
reduce the risk of infection caused by food borne pathogen. Edelson-Mammel and Buchanan 
(2004) investigated the effect of reconstituting PIF with water of different temperatures on 
Cronobacter inactivation and concluded that preparing PIF with water of 70°C or greater 
lead to a more than 4-log reduction in Cronobacter levels. Based on their findings, 
FAO/WHO (Anonymous, 2007c) recommended use of water ≥ 70°C to reduce the infection 
risk in infants associated with Cronobacter contamination. Besides thermal inactivation, 
there has been an increasing interest in introducing external hurdles via incorporation of 
various natural antimicrobials to control Cronobacter in PIF. Lactoferrin and nisin have 
been shown to have detectable antimicrobial activity against Cronobacter depending on 
concentration and temperature (Al-Nabulsi et al., 2009). Gurtler and Beuchat (2007) 
reported that lactoperoxidase inhibited the growth of Cronobacter in reconstituted PIF. 
Plant-derived essential oils including caprylic acid and trans-cinnamaldehyde have been 
determined to be effective agents in the suppression of Cronobacter in reconstituted infant 
formula as well as in the inhibition and inactivation of Cronobacter biofilms (Amalaradjou 
et al., 2009; Amalaradjou and Venkitanarayanan, 2011). A study of Kim et al. (2009) 
concluded that muscadine seed extracts, as rich sources of phenolic compounds and organic 
acids, displayed a strong antimicrobial activity against Cronobacter strains which was 
mainly caused by organic acids like tartaric, malic and tannic acid. Back et al. (2009) 
screened the inhibitory effects of eight organic acids and found propionic and acetic acid as 
most effective against Cronobacter in liquid foods including baby food. Commercially 
available acidified infant formula by direct addition of lactic acid in 1.4 g/100 g of dry 
composition has been shown to be effective in limiting Cronobacter (Kreb, 2010). Besides 
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direct addition of organic acids in PIF as an alternative acidification intervention has been 
developed through the fermentation of the basic ingredients of infant formula with lactic 
acid bacteria. In a study of Joosten and Lardeau (2004), a commercially available 
biologically acidified (fermented) infant formula showed a clear bacteriostatic effect on 
pathogenic bacteria including Cronobacter spp.. 
 
1.7 Growth of Cronobacter in rehydrated PIF and Raw 
Materials as a Prerequisite for a Successful Detection  
Except for one method developed by AES Laboratories which directly starts with an 
enrichment in a selective medium Enterobacter sakazakii selective broth (ESSB), all 
culture-based methods published to date including the FDA reference method and the ISO 
standard method involve an initial non-selective pre-enrichment step where PIF is diluted in 
a ratio of 1:10 in distilled water or in BPW and incubated at 37°C for 16-20 h (Fanning and 
Forsythe, 2008; Kandhai, 2010; Lampel and Chen, 2009). In addition, rapid methods such as 
PCR, real time PCR or impedance have to be combined with the pre-enrichment step as well 
due to the necessity for reconstitution of stressed Cronobacter cells in PIF and for 
acquisition of minimal cell numbers required for detection limit. The Cronobacter growth in 
reconstituted PIF during the pre-enrichment stage is hence an extremely important 
prerequisite for the whole detection, because the following isolation and confirmation steps 
would not make sense unless a sufficient growth of target micro-organism is guaranteed in 
the pre-enrichment broth. According to ISO/TS 22964:2006, 0.1 ml from the overnight 
pre-enrichment is applied in 10 ml mLST for further isolation. In order to make sure that at 
least 1 CFU Cronobacter would be included in this 0.1 ml aliquot, Cronobacter cells 
initially present at low levels in 100 g PIF must theoretically increase to a minimal density 
of 9000 CFU in 900 ml pre-enrichment broth after overnight incubation at 37°C. Conversely, 
no Cronobacter is detectable if this lowest detection limit in the pre-enrichment is not 
achieved. Using the same simplistic model of Iversen and Forsythe (2003) which assumed 
an average of 0.36 Cronobacter cells/100 g PIF, lag time of 2 h and doubling time of 0.5 h at 
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37°C, it can be calculated that 100 g PIF reconstituted in 900 ml water would need to be 
kept for approximately 7.5 h at 37°C before a cell number of Cronobacter of 9000 CFU is 
achieved. It implies that at ideal conditions a sufficient Cronobacter growth can be ensured 
during the pre-enrichment. In the reality, nevertheless, any non-target micro-organisms 
present in the sample that are able to grow in BPW or water might compete with 
Cronobacter during the pre-enrichment and further reduce the numbers of target colonies 
transferred into selective broth. In addition, special PIF products with antimicrobial agents 
have been shown to limit the Cronobacter growth. In commercially available biologically 
acidified infant formulae e.g. NAN PELARGON
® 
as well as in acidified formula 
supplemented directly with organic acid, concentration of Cronobacter cells after 6 h 
incubation at 30°C were restricted to 10 CFU/ml comparative to the initial spiking level, 
while in the non-acidified formula Cronobacter grew to as high as 10
5
 CFU/ml (Kreb, 2010). 
In the investigation of Joosten and Lardeau (2004), similarly, Cronobacter levels over a 
period of 6 h at 37°C in rehydrated acidified formula were 1000-fold lower than that 
detected in non-acidified formula. Oshima et al. (2012) screened thirty-three antimicrobial 
agents including peptides, organic acids, organic acid esters and lactoperoxidase system 
(LPOS) etc. for their anti-Cronobacter activity and determined final numbers of C. sakazakii 
grown in reconstituted milk powder at 37°C after 8 h at a very low level of < 1 log CFU/ml 
in the presence of LPOS combined with nisin or lacticin, showing the most potential in 
Cronobacter inhibition, whereas in the controlling infant formula group without these 
additives a high number of Cronobacter in 7 log CFU/ml was detected. Although the 
antimicrobial hurdles added to PIF have been shown to be beneficial in protecting against 
Cronobacter overgrowth due to inhibitory interactions, there is risk of target micro-organism 
not reaching the required cell limit in the reconstitution stage, which could lead to a false 
negative outcome by detection. It is strongly emphasized that samples from which no 
Cronobacter is detectable do not necessarily indicate their microbiological safety. Therefore, 
the limited growth of Cronobacter in PIF or PIF additives must be taken into consideration 
when a method for Cronobacter detection is developed, validated or applied.  
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1.8 Prevalence of non-Cronobacter Enterobacteriaceae in 
PIF and the related influence on Cronobacter Identification  
Mutyjens et al. (1988) were the first to assess the microbiological quality of powdered 
substitutes for breast milk with regard to members of Enterobacteriaceae family. 
Enterobacter (E.) agglomerans has been found to be present in PIF most frequently with 
27% of all isolates, followed by Enterobacter (E.) cloacae with 23% and Klebsiella (K.) 
pneumoniae with 10%. However the identity of E. agglomerans in this study is uncertain 
because since the revision of Enterobacter-Pantoea-Citrobacter group, the former E. 
agglomerans now encompasses both Pantoea spp. and Escherichia vulneris (Janda and 
Abbott, 1998). In another survey performed by Iversen and Forsythe (2004), a distribution 
of most common organisms for E. cloacae (25%) and Pantoea (P.) spp. (19%) was 
described. Estuningsih et al. (2006) found 24% P. agglomerans, 20% Escherichia hermanni, 
16% E. cloacae and 6% K. pneumoniae in PIF products manufactured in Indonesia and 
Malaysia. E. cloacae and E. agglomerans were isolated from 15 infant food formula 
products in UK (Shaker et al., 2007). Popp et al. (2009) reported E. cloacae, K. pneumoniae, 
K. oxytoca and Pantoea spp. as most frequently isolated Enterobacteriaceae species from 
infant formula products. These available data allow the conclusion that besides Cronobacter 
spp., the most dominant Enterobacteriacea isolated from PIF included Enterobacter species, 
Pantoea species, and Klebsiella species. The available data do not indicate any relationship 
between Enterobacteriaceae and Cronobacter present in PIF samples. However neither is it 
possible to rule out a possible correlation with the available data. Cordier (2008) has shown 
that high levels of Enterobacteriaceae > 100 CFU/g are likely to represent an increased risk 
of product contamination with Cronobacter. Monitoring of Enterobacteriaceae is used as an 
indicator of hygienic status in production facilities (Anonymous, 2007b). As shown in the 
microbiological criteria for PIF applied by the European Commission, EC No 1441/2007 
(Anonymous, 2007a), the detection of Enterobacteriaceae is a process hygienic criterion, 
while Salmonella and Cronobacter spp. serve as food safety criteria (Table 1).  
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Table 1. Current microbiological criteria for dried infant formula for infants up to 6 months 
of age and for formulae for special medical purposes of European Union 
 
Micro-organisms  n c m M  
Enterobacteriaceae (10 g) 10 0 0/10 g NA Process hygienic parameter 
Cronobacter spp. (10 g) 30 0 0/30 g NA 
Food safety parameters 
Salmonella (25 g) 30 0 0/30 g NA 
n is the number of samples to be analyzed per lot; 
c is the number of samples allowed between “m” and “M” value; 
m is the microbiological limit separating good from marginally acceptable quality; 
M is the microbiological limit separating marginally acceptable from unacceptable quality. 
 
Based on findings of Guillaume-Gentil et al. (2005) and Nazarowec-White and Farber 
(1997b) that Cronobacter spp. showed a higher tolerance against osmotic stress and heat 
stress than most of other Enterbacteriaceae competitors except for four strains of E. 
hermanni, E. cloacae, K. oxytoca and K. pneumoniae, the new ISO specification for PIF 
ISO/TS 22964:2006 has been developed using mLST as the selective enrichment broth 
(Anonymous, 2006b). However, either using the selective enrichment media combined with 
elevated temperature in ISO method or using the non-differential FDA enrichment 
procedure, Enterobacteriaceae in different genera and species have been isolated from PIF, 
environmental samples or foods other than infant formula where competitive flora 
quantitatively occurred (Baumgartner et al., 2009; Iversen et al., 2009; Lehner et al., 2010; 
Shaker et al., 2007).  
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Objectives of the study 
Consumption of reconstituted PIF contaminated with Cronobacter spp. has been shown to 
be associated with a high risk of infection diseases in infants. The present work aimed to get 
more insight into the effect of using hot water with a temperature of 70°C or higher for PIF 
rehydration on the growth and survival of Cronobacter present in fermented and 
non-fermented infant formula (Chapter 2). As an alternative to thermal inactivation, the 
influence of organic acids as natural antimicrobial barrier on the growth of Cronobacter spp. 
in laboratory medium as well as in the reconstituted PIF was investigated. Particularly the 
anti-Cronobacter effect of most inhibitive organic acids was studied under natural infant 
stomach acidity (Chapter 3). Due to the antimicrobial compounds or competing flora in PIF, 
the growth of Cronobacter spp. in the pre-enrichment stage can be inhibited, which could 
influence principally the overall effectiveness of the Cronobacter detection method. A newly 
developed impedance method combined with rRNA lateral flow assay for detection of 
Cronobacter spp. in PIF was evaluated, with possible effect of organism’s history (healthy 
or stressed) and competing background flora assessed (Chapter 4). At last, various systems 
for the isolation, identification and differentiation of Cronobacter spp. from other 
micro-organisms with a common presence in PIF have been comparatively assessed in view 
of their sensitivity, selectivity, discrimination power, rapidity as well as convenience in 
performance (Chapter 5 and Addendum).  
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Abstract 
The presence of Cronobacter spp. in powered infant formula (PIF) has been associated to 
outbreaks of rare, but life-threatening cases of meningitis, necrotizing enterocolitis, and 
sepsis in newborns. This study was undertaken to explore the influence of reconstitution 
water of 70°C or higher on survival of Cronobacter spp. in PIF. A higher final temperature 
was obtained in plastic baby bottles than glass baby bottles after PIF was mixed with water 
of the same temperature. An average reduction in Cronobacter levels of 3.6 log was 
achieved if contaminated PIF was prepared with water at 80°C in plastic bottles. The 
inhibitory effect on Cronobacter in fermented infant formula (FIF) was reduced by 
reconstituting the formula with water of 80°C. Reconstitution temperature of 80°C did not 
lead to a greater reduction in vitamin C concentration in PIF compared to lower 
reconstitution temperatures of 20°C and 40°C.  
 
Introduction 
Cronobacter species, formerly known as Enterobacter sakazakii, are Gram-negative, 
rod-shaped pathogenic bacteria of the family Enterobactericeae. These organisms have been 
implicated as causes of life-threatening infections like meningitis, necrotizing enterocolitis 
and bacteremia predominantly in infants < 4 weeks of age with a mortality rate of 20%-50% 
(Anonymous, 2007a; Clark et al. 1990; Lehner and Stephan, 2004). Powdered infant 
formula (PIF) is not a sterile product. Contamination of PIF can occur intrinsically during 
the manufacturing process or from extrinsic sources through contaminated utensils (e.g. 
spoons, blenders, teats, bottles) (Anonymous, 2007b). PIF contaminated with Cronobacter 
spp. has been microbiologically and epidemiologically shown to be the vehicle and source 
of infection in infants. Heat treatment of food just prior to consumption has been used as a 
primary tool to reduce the risk associated with foodborne pathogens (Edelson-Mammel and 
Buchanan, 2004). FAO/WHO (Anonymous, 2007b) recommended reconstitution of PIF 
with water at 70°C or higher to reduce the potential risk associated with Cronobacter 
contamination. However, heating infant milk to ≥ 70°C raises other concerns such as loss of 
heat-sensitive nutrients and an increased risk of scalding. Besides, the high reconstitution 
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temperature may be inadequate for some PIF products containing probiotics because they 
could be killed by water of ≥ 70°C (Anonymous, 2006). This study was undertaken to 
evaluate the effect of preparing PIF and FIF with water ≥ 70°C on survival of Cronobacter.  
 
Materials and Methods 
Temperature of rehydrated PIF in baby bottles prepared with water at 70°C and 80°C 
The tap water was first boiled in an electric kettle. The freshly boiled water was left at the 
room temperature to cool down to 80°C and 70°C respectively. According to the preparation 
instruction, 90 ml water were added to sterilized baby bottles made of glass and of plastic 
respectively. Three scoops (13.5 g) of PIF were added to the water. In the same manner, five 
scoops (22.5 g) PIF were dissolved in 150 ml water in glass and plastic baby bottles. The 
bottles were caped and gently agitated by hand at room temperature for 10 seconds. The 
temperature of rehydrated PIF in baby bottles was measured and three independent trials 
were performed. 
 
Survival of Cronobacter strain in PIF prepared with water of 80°C 
Commercially available PIF products were first screened for absence of Cronobacter spp. 
with ISO/TS 22964. 90 ml water of 80°C were poured in to a sterilized plastic baby bottle 
prior to adding 3 scoops of PIF. The rehydrated PIF was inoculated with 1 ml fresh 
overnight culture of C. sakazakii CLF2688 at levels of 10
8
, 10
7
, 10
6
 and 10
5
 and 10
4 
CFU/90 
ml respectively. The bottle was left at room temperature for 2 min and then cooled under the 
running tap water to 37°C. The C. sakazakii count in the bottle was determined by 
spread-plate technique using Brilliance
TM
 E. sakazakii chromogenic agar 
Druggan-Forsythe-Iversen (DFI) formulation (Oxoid, UK). Three independent trials were 
performed. 
 
Impact of reconstitution temperature of 80°C on the antibacterial effect of FIF 
FIF in different fermentation levels (0%, 30%, 50% and 100%) were applied in this test. A 
non-fermented neutral PIF starter product served as reference. In the first group, 1-10 CFU 
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C. sakazakii (CLF2688) were added to 90 ml reconstituted FIF and PIF which were 
prepared with water of 40°C in a plastic baby bottle. To investigate the effect of a higher 
reconstitution temperature on the inhibitory activity of FIF against Cronobacter, 90 ml FIF 
and PIF were first prepared with water at 80°C and left at room temperature for 2 min. After 
being cooled down to 40°C under the running tap water, the infant formulae were artificially 
spiked with 1 ml C. sakazakii (CLF2688) in 1-10 CFU/90 ml of diets. Inoculated infant 
formulae in both groups were stored at room temperature for 24 h. The Cronobacter growth 
was followed by enumeration with DFI chromogenic agar after 5 and 24 h. Three 
independent trials were performed. 
 
Vitamin C concentration in PIF prepared with water of 20°C, 40°C and 80°C 
12.20 g commercially available PIF product were weighed in the flask and filled with 100 
ml water of 20°C, 40°C and 80°C respectively. The flask was well shaken and stored at a 
household fridge temperature of 9°C for 8 h. The concentration of vitamin C in rehydrated 
PIF was determined with a potentiometric method on titrator (Mettler TOLEDO T50, 
Germany) using 2,6-dichchlorophenolindophenol at 0 h, 4 h and 8 h.  
 
Statistic analysis 
Data were analyzed with Student’s t test using Microsoft® Excel 2003 software. Significant 
differences are presented at a 95% confidence level (p < 0.05). 
 
Results 
Compared with initial water temperatures of 70°C and 80°C added to bottles, the 
temperatures after PIF-mixing decreased in all bottle/serving volumes combinations (Table 
1). However for both 90 ml and 150 ml serving volumes, the temperature in rehydrated PIF 
dropped to a less extend in bottles made of plastic than that of glass. Besides, a more rapid 
decrease in temperature after PIF-mixing was observed in smaller serving volume of 90 ml 
than in larger volume of 150 ml in glass bottles, while the final temperatures in plastic 
bottles did not differ between rehydration quantities. 
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Table 1. Temperature of rehydrated infant formula after hot water of 70°C and 80°C was 
added to glass and plastic baby bottles containing PIF 
 
 PIF reconstitution temperature 
Water quantity 70°C  80°C 
 Glass bottle Plastic bottle  Glass bottle Plastic bottle 
90 ml 54°C 62°C  63°C 70°C 
150 ml 58°C 62°C  65°C 70°C 
 
As higher final temperatures were reached in PIF rehydrated with water of 80°C than 70°C, 
the water of 80°C was used for preparing PIF in the following tests. With rehydration 
temperature of 80°C, the observed Cronobacter cell reduction in plastic bottles ranged from 
3.5 log to 4.4 log when initial counts exceeded 10
6
 CFU/90 ml, whereas in glass bottles a 
higher Cronobacter surviving number was obtained at initial inoculums of 10
8
, 10
7 
and 10
6
 
CFU. Especially at higher inoculums of 10
8
 and 10
7
 CFU Cronobacter cells, the thermal 
inactivation effect of preparing PIF with water at 80°C was very pronounced in plastic 
bottles: a 200 to 300 fold higher C. sakazakii counts surviving in glass bottles were obtained 
than in plastic ones. At lower inoculum of 10
6
 CFU, the difference in Cronobacter survival 
between bottles of two materials was minimal, while at a contamination level of 10
5
 CFU, 
Cronobacter counts dropped in both kinds of bottles to 10
2
 CFU. For an inoculum of 10
4
 
CFU/90 ml PIF, the reduction was greater than 2 log and this is below the lowest detection 
limit of 1 CFU/ml corresponding to limit of detection (LOD) of 1.9 log CFU/90 ml (Table 
2). 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
32 
 
Table 2. Survival of C. sakazakii (CLF2688) during the rehydration of PIF with water of 
80°C at different initial contamination levels 
 
 Surviving Cronobacter (log CFU/90 ml) in Mean ± SD 
Initial inoculum of Cronobacter in 
infant formula (log CFU/90 ml) 
Glass bottle Plastic bottle 
8 6.2 ± 0.3 3.7 ± 0.3 
7 5.2 ± 0.2 2.8 ± 0.1 
6 3.1 ± 0.1 2.5 ± 0.3 
5 2.2 ± 0.5 2.5 ± 0.2 
4 < 1.9
 a
 < 1.9
 a
 
a 
Lower limit of detection: 1 CFU/ml = 90 CFU/90 ml (log 90 CFU/90 ml = 1.9) 
 
After 5 h incubation at room temperature, the C. sakazakii populations were between 2 and 
3 log CFU/ml in all products but in the 100% fermented FIF, regardless of reconstitution 
temperatures. In the FIF fermented to 100%, a slight but significant reduction in 
Cronobacter growth by 0.7 log was shown for reconstitution with 40°C when compared 
with the same product treated previously with water of 80°C (Fig. 1). On the other hand, 
among all products rehydrated with an ambient water temperature of 40°C as recommended 
by manufacturer, only limited inhibitory effect was shown in FIF fermented to 100% and no 
antibacterial effect was visible in formulae fermented to 30% and 50% compared with 
non-fermented FIF or reference PIF. In the group rehydrated with water of 80°C, the target 
micro-organism was able to grow to ≥ 7 log CFU/ml in all products within 24 h incubation, 
while a significant cell reduction ranging from 1.5 log to 2.4 log was shown in FIF 
fermented in 30%, 50% and 100% when prepared with water of 40°C (Fig. 2). The pH 
values at 0 h were 6.70, 6.25, 6.00, 5.60 and 6.80 for FIF fermented to 0%, 30%, 50%, 
100% as well as in the control PIF respectively. After 5 h incubation slightly enhanced pH 
values were obtained for all products. After 24 h incubation decreased pH values of 4.16, 
4.15 and 4.30 were obtained in FIF fermented to 30%, 50% and 100%. No obvious pH drop 
was observed in non-fermented FIF and reference product. 
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Figure 1. Growth of C. sakazakii (CLF2688) (log CFU/ml) in FIF/PIF hydrated with 40°C 
and 80°C after 5 h incubation at 22°C with an initial inoculum of 1-10 CFU Cronobacter/90 
ml. Value with * is significantly different (p < 0.05) with remaining values without *. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
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Figure 2. Growth of C. sakazakii (CLF2688) (log CFU/ml) in FIF/PIF hydrated with 40°C 
and 80°C after 24 h incubation at 22°C with an initial inoculum of 1-10 CFU 
Cronobacter/90 ml. Values with * are significantly different (p < 0.05) with remaining 
values without *. The three values with * revealed no significant differences with each other 
(p > 0.05). 
 
 
As shown in Fig. 3, the vitamin C concentrations in rehydrated PIF were at the beginning 
14.9, 14.5, 14.6 mg/100 ml and were reduced to 10.7, 10.2 and 10.9 mg/100 ml for 
preparation water temperature of 20°C, 40°C and 80°C respectively after 8 h storage at 9°C, 
which indicates that the vitamin C reduction caused by a high preparation temperature did 
not differ from that at lower temperatures.  
 
 
 
 
 
 
 
* 
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Figure 3. Vitamin C concentration in PIF rehydrated with water of 20°C, 40°C and 80°C 
over 8 h at a household fridge temperature. 
 
Discussion 
In Germany, use of water at 40°C or 50°C for reconstituting PIF is recommended by the 
manufacturers for products such as Milumil, Aptamil, Hipp and Alete. However, FAO/WHO 
(Anonymous, 2006) performed a risk assessment model for Cronobacter in PIF and 
concluded that PIF reconstitution with water at 40°C and 50°C is highly associated with an 
increased risk of Cronobacter infection. Edelson-Mammel and Buchanan (2004) reported 
that using water at 70°C or greater for PIF preparation was able to cause a more than 4-log 
reduction in Cronobacter levels and could therefore significantly reduce the risk of infection. 
In addition, Chen et al. (2009) showed less survival of Cronobacter cells in reconstitution 
water ≥ 70°C in larger volumes than in smaller volumes because a higher temperature was 
maintained for a longer time in larger volumes, exhibiting a more pronounced lethality 
effect. In the present work, temperature differences between PIF prepared in smaller and 
larger volumes were only observed in feeding bottles made of glass. It is known that lower 
final temperatures achieved in PIF after reconstitution water is added allow a better survival 
of Cronobacter cells (Chen et al., 2009; Kim and Park, 2007). Due to the fact that younger 
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infants often receive liquid formula prepared in a smaller quantity per feeding than older 
infants and the younger babies are more vulnerable to Cronobacter infections than older 
babies (Anonymous, 2006), the consumption of contaminated PIF in a smaller serving 
volume could therefore pose a high risk of Cronobacter infection particularly to infants at 
younger age. As shown in Table 1, the highest final temperature of 70°C was achieved in 
PIF prepared with water of 80°C in plastic bottle regardless of serving volumes, while the 
lowest final temperature of 54°C after PIF-mixing was obtained in 90 ml PIF rehydrated 
with water of 70°C in glass bottle. This might indicate that the plastic bottle can hold heat 
for longer period of time than glass one probably due to the high capacity of glass material 
for heat absorption. The temperature drop in PIF after it was mixed with hot water has been 
documented in various previous studies (Chen et al., 2009; Edelson-Mammel and Buchanan, 
2004; Kim and Park, 2007). However, no information about the material of baby bottles 
used was given in details: while only a rough description as “feeding bottles” or “baby 
bottles” was given in publications of Edelson-Mammel and Buchanan (2004) and Kim and 
Park (2007), Chen et al. (2009) did not mention at all in what kind of container the PIF was 
reconstituted and the growth of Cronobacter was determined. From the data presented in 
Table 1, it is evident that the material of baby bottles represents an important determinant 
for temperature drop in rehydrated PIF impacting the Cronobacter survival. In the present 
work, rehydration of 90 ml PIF in 80°C hot water resulted in greater than 3 log and 2 log 
reduction in the Cronobacter strain tested in plastic and glass bottle respectively (Table 2). 
By contrast, in the pilot study of Edelson-Mammel and Buchanan (2004), a stronger effect 
of reconstitution water of 80°C on Cronobacter inactivation in PIF of ≥ 4 log has been 
reported. However it must be noted that in their investigation a higher volume of formula 
(180 ml) was prepared using 25.5 g PIF contributing to decrease of temperature in a less 
extent and further a lower Cronobacter survival. In the study of Chen et al. (2009), 
Cronobacter cell inactivation of greater than 4 log by using water of 80°C was observed on 
two pre-selected heat-sensitive target strains inoculated in larger serving volumes. Last but 
not least, different incubation time could be responsible for the observed differences in 
Cronobacter survival rate as well. In the present study the heat in PIF prepared with hot 
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water of 80°C was kept for 2 min before Cronobacter counts were determined, whereas the 
bottles were hold for 10 min and analyzed for Cronobacter by Edelson-Mammel and 
Buchanan (2004). A relative low level of Cronobacter cells of 0.36 to 66 CFU 
Cronobacter/100 g PIF has been determined by Muytjens et al. (1988). This implies that 
preparing reconstituted formula using the best option presented here (80°C in plastic bottle) 
is likely to result in a high probability that a serving would not contain this micro-organism. 
Concerns have been raised in using water of ≥ 70°C to prepare PIF due to possible loss of 
nutrient in product or inactivation of probiotic added in specialized infant formula 
(Anonymous, 2006). Fermented infant formula is infant formula fermented with lactic 
acid-producing bacteria e.g. Bifidobacterium and Streptococcus during the production 
process. The FIF in the present work is based on a mixture of fully fermented PIF and 
non-fermented PIF product. The fermentation levels of FIF refer to the percentage of fully 
fermented product in the whole mixture. FIF usually contains low numbers of viable 
bacteria (< 10
3
 CFU/g dry weight) in the final product due to the inactivation of the 
fermenting bacteria by physical treatment. Clinical trials have shown that some FIF could 
reduce the occurrence or severity of infectious diarrhea in infants which is likely to be 
associated with its bacteriostatic effect (Brunser et al., 1989; Joosten and Lardeau, 2004; 
Thibault et al., 2004). It has been concluded that the additional benefits of FIF result from 
the remaining bacterial components such as cell membrane or bacterial DNA, and/or 
bacterial metabolites such as organic acids or protein with enzyme activity rather than 
surviving intact living bacteria (Agostoni, et al., 2007; Ludwig, et al., 2012). As shown in 
Fig. 2, the FIF fermented to 30%, 50% and 100% showed an inhibition effect on 
Cronobacter growth in 24 h if rehydrated with water at 40°C. The cell reduction might be 
caused by the relatively lower pH values in these products after 24 h incubation. No 
inhibitive effect was demonstrated in FIF when it was prepared with 80°C water, indicating 
the thermal sensitivity of the compositions produced by fermentation. On the other hand, the 
inhibition effect of FIF is very limited. In FIF with lower fermentation levels of 30% and 
50%, Cronobacter grew to higher than 100 CFU/ml equivalent to 9000 CFU/90 ml diet 
within 5 h at room temperature of 22°C if the PIF was reconstituted with water of 40°C 
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according to recommendation. 5 h is regarded as a critical timeframe in consumer practices 
where an extended feeding or holding can really occur. Most importantly, the cell 
concentration of 9000 CFU/90 ml exceeds the infectious dose of 1000 CFU estimated by 
Iversen and Forsythe (2003) and is very close to the infectious level of 10,000 CFU 
proposed by FAO/WHO (Anonymous, 2007a). In 24 h Cronobacter grew to a cell density of 
between 10
5 
and 10
6 
CFU/ml in FIF treated with water of 40°C, posing a high risk of 
infection. By comparison, the alternative Cronobacter inactivation strategy by using water 
of ≥ 70°C for reconstitution which should provide virtually instantaneous inactivation of this 
micro-organism is presumed to kill all Cronobacter cells present initially at low level in 
infant formula and is therefore likely to control the risk more effectively. Reduction of 
vitamin C ranging from 5.6% to 65.6% in four particular formulae due to preparation with 
boiling water has been noted in the report of the FAO/WHO expert meeting (Anonymous, 
2006; Anonymous, 2007b). To solve this problem, dry formulae actually contain higher 
levels of vitamin C than labelled. After reconstituting with boiling water, the vitamin C 
levels in the four formulae mentioned above still exceeded the can label or were higher than 
the minimum recommendation (8 mg vitamin C/100 calories) required by the CAC Codex 
Standard for Infant Formula (Anonymous, 1981). Based on data in Fig. 4, the vitamin C 
concentration in reconstituted PIF decreased over the incubation duration at refrigerator 
temperature. However the reduction of vitamin C is not directly related to the enhanced 
water temperature. Rehydration of PIF with 80°C water resulted in a slighter vitamin C 
reduction of 18% and 25% at 4 h and 8 h respectively than reductions achieved with 20°C 
(21% and 30%) and 40°C (18% and 28%).  
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6.1 Inactivation of Cronobacter in Reconstituted PIF 
PIF is not a sterile product. Being a nutrient-rich medium, reconstituted PIF provides a good 
substrate for growth of Cronobacter spp. (Nazarowec-White and Farber, 1997b). Once 
rehydrated, storage time and temperature have been considered as only limiting factors for 
bacterial growth and related infection (Amalaradjou et al., 2009). Rapid generation times of 
Cronobacter of 37-44 min and 19-21 min at 22°C and 37°C, respectively, have been 
reported by Iversen et al. (2004b) and Nazarowec-White and Farber (1997a). The 
FAO/WHO Expert Group developed a quantitative risk assessment model in which the risk 
of Cronobacter infection posed to infants from intrinsically contaminated PIF was estimated 
and concluded that improper reconstitution water temperature, holding bottles at room 
temperature and prolonged feeding periods and storage practices could lead to an increased 
risk of Cronobacter infection (Anonymous, 2006a).  
 
Thermal treatment of food right prior to consumption has long been used as a primary tool 
of reducing the contamination risk of pathogens. Use of heat-treated water for PIF 
reconstitution to eliminate Cronobacter may represent a final opportunity to prevent 
infection. However, the recommendations on the product labelling given by manufacturer 
for PIF reconstitution temperature are inconsistent between different countries: water of 
20°C, 40°C, 50°C and at least 70°C is recommended for PIF reconstitution in France, 
Germany, Japan and UK. As predicted by FAO/WHO, PIF reconstitution with water 40°C or 
50°C (unless consumed immediately) is associated with the greatest risk of Cronobacter 
infection (Anonymous, 2006a). In a preliminary experiment in the present work, when 90 
ml PIF spiked with C. sakazakii CLF2688 at a low level of 1-10 CFU was reconstituted with 
water of 40°C, temperature in rehydrated PIF decreased to 37°C and an appreciable bacteria 
growth up to 100-1000 CFU/90 ml occurred after incubation at 37°C for 2 h. Iversen et al. 
(2004) reported 35-37°C as the optimal growth temperature for Cronobacter. Mixing water 
of 30-50°C did not cause a substantial inactivation of Cronobacter in PIF but provided 
conditions favourable for bacteria growth (Chen et al., 2009; Kim and Park, 2007). It must 
be noted that in the risk assessment model of FAO/WHO (Anonymous, 2006a) the results 
CHAPTER 6 
 
64 
 
are presented as relative risk based on definitive preparation scenarios. Bacterial growth in 
infant gastrointestinal tract after PIF consumption was not taken into consideration and the 
highest environmental temperature simulated in the model was 30°C instead of a 
physiological infant body temperature of 37°C. Using the calculation of gastric emptying 
reported in Chapter 3, the infectious dose of 1000 CFU for Cronobacter proposed by 
Iversen and Forsythe (2003) would be easily exceeded during stomach emptying by the 
consumption of contaminated PIF reconstituted with water of 40°C. Even the higher 
infectious dose of 10,000 CFU estimated by FAO/WHO (Anonymous, 2007a) could be 
achieved in a preterm infant with an extremely prolonged gastric emptying time of 21 h. The 
rapid growth of Cronobacter at ambient temperatures indicates that even if the PIF 
reconstituted with water of 40°C or 50°C is consumed immediately, it apparently still poses 
an enhanced risk of infection under infant physiological conditions. FIF has proven to be 
effective in inhibiting pathogen due to competition for nutrients and production of 
antimicrobial substances (Agostoni et al., 2007). In the present work, only limited 
bacteria-killing effect of FIF was demonstrated. In the FIF product fermented to 100% 
where the most pronounced inhibitory effect was demonstrated, the Cronobacter grew from 
a low initial level to a relatively high level close to the infectious dose 5 h after FIF was 
mixed with water of 40°C as recommended. It suggests that the risk associated with 
Cronobacter is still likely to exist if FIF is reconstituted with water of 40°C and the 
reconstituted FIF is kept for an increased hang-time.  
 
Edelson-Mammel and Buchanan (2004) were the first to report a greater than 4 log 
reduction of Cronobacter by rehydrating PIF with water ≥ 70°C. Consequently, the 
FAO/WHO (Anonymous, 2007b) has recommended rehydration of PIF with water at 70°C 
or higher to reduce the potential infection risk associated with Cronobacter contamination. 
In the present work, water of 70°C and 80°C was used to mix PIF and lower temperatures 
were obtained in rehydrated PIF. We are the first to indicate that not only the serving 
volumes, but the material of baby bottles as well can influence the decline of temperature in 
rehydrated PIF. Chen et al. (2009) reported higher temperature of reconstituted PIF when a 
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larger amount of water was mixed with PIF, which could be explained by the slower cooling 
pattern of the container for larger servings. Correspondingly, in the same study a lower 
number of survivors as well as a retarded growth of Cronobacter spp. has been recorded in 
two serving (120 ml) than in single serving (60 ml) preparation(s) of PIF reconstituted with 
water of same temperature. Notable that compared with older babies, the more vulnerable 
neonates ≤ 28 days are usually fed on infant formula in smaller volumes and could thus be 
exposed to a higher risk of Cronobacter infection.  
 
As shown in Table 2 Chapter 2, 90 ml PIF rehydrated with water of 80°C lead to a greater 
Cronobacter cell reduction in average in plastic bottle (3.6 log) than in glass one (2.3 log), 
which could be due to the higher temperature of rehydrated PIF in the plastic container with 
a better heat preservation capability (Table 1 Chapter 2). Moreover, the Cronobacter 
reduction in plastic bottle was < 4 log for lower inoculums and > 4 log for higher inoculums. 
This is probably explained by the uneven heating of rehydrated PIF caused by insufficient 
shaking, which could lead to lower than anticipated microbial inactivation in cold points 
where bacteria are clustered.  
 
Thermal inactivation effect of hot water on Cronobacter in reconstituted PIF has been 
reported by other investigators: Chen et al. (2009) reported no inactivation and 4-6 log 
reduction in Cronobacter numbers using water of 50°C and 90°C respectively. For two heat 
resistant strains in single serving a decrease in cell counts by 1-2 log at 60°C and 70°C was 
achieved. Kim and Park (2007) studied the inactivation of one Cronobacter isolate during 
PIF rehydration and reported reduction by 1-2 log at 60°C and 4-6 log at 65°C and 70°C. 
Kindle et al. (1996) reported over 4 log reduction at 82°C-93°C for 85-93 sec by 
microwaves. Despite serving volume and container materials, other factors like initial 
reconstitution water temperature, cooling duration and environmental temperature could 
influence the “final real temperature” in rehydrated PIF and consequently the surviving rate 
of Cronobacter. On the other hand, thermal inactivation is strongly strain dependent (Chen 
et al., 2009). Thermal stability of Cronobacter isolates varied as much as twentyfold 
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(Edelson-Mammel and Buchanan, 2004). All biochemical differences between strains (e.g. 
heat sensitive or not; type strain or capsulated strain; heat injured or not) are responsible for 
diversity of heat resistance among Cronobacter strains (Chen et al., 2009; Kim and Park, 
2007). Furthermore, nutritional aspects of media as well as components in different infant 
formula formulations (sugar and fat concentration, total solid content) may influence the 
thermal resistance of bacteria and further the bacterial survival during heat treatment (Chen 
et al., 2009; Nazarowec-White and Farber 1997c). 
  
To date low levels of Cronobacter have been found in PIF in most cases ranging from 0.36 
to 66 CFU/100 g (Muytjens et al., 1988). The most highly contaminated PIF cluster 
contained 560 Cronobacter cells/g which corresponds to a cell density of approximately 
5600 CFU/90 ml infant formula (Jongenburger et al., 2011). Even at this worst case scenario 
the heat treatment with 80°C water is likely to result in a high probability that no target 
organism would be present in a single serving anymore, thereby reducing the infection risk 
associated with consumption of contaminated PIF. Although the antimicrobial effect of FIF 
was slightly affected by heat treatment with water of 80°C, this effect which is linked to 
bacterial competition or lowered pH is not strong enough to replace the effectiveness of 
thermal inactivation of pathogens using hot water ≥ 70°C for reconstitution. Loss of vitamin 
C by preparing PIF with boiling water varied between different infant formula formulations. 
Data shown in the present study (Fig 3, Chapter 2) suggest no effect of water of 80°C on 
substantial vitamin C reduction. 
 
According to FAO/WHO recommendation (Anonymous, 2007b), the PIF is prepared with 
water ≥ 70°C, cooled to feeding temperature under a running tap and fed immediately. Any 
feed that has not been consumed within two hours has to be discarded. Although it is 
recommended to make PIF fresh for each feed, for practical reasons, feeds need to be 
prepared in advance. Prepared feeds should be stored in the refrigerator of no higher than 
5°C of maximally up to 24 h. 
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Besides loss of heat-sensitive nutrients, other concerns about using water ≥ 70°C for PIF 
reconstitution such as a scalding risk and clumping of the powder have been raised 
(Anonymous, 2006a). Although these potential problems can be avoided by careful handling 
or technological improvement, unfortunately, the FAO/WHO recommendation is not always 
followed. Fein and Falci (1999) and Herbold and Scott (2008) reported a high percentage of 
mothers who failed to comply with PIF preparation and feeding instructions. It poses a high 
risk of recontamination of prepared PIF from unwashed hands, utensils, insects, etc. before 
it is consumed. Therefore, there is increasing interest in fortifying PIF with antimicrobial 
barrier to allow for reconstitution at lower temperatures. The use of various natural 
antimicrobials to limit Cronobacter growth in rehydrated PIF or milk products e.g. 
lactoperoxidase (Gurtler and Beuchat, 2007), probiotics (Osaili et al., 2008; Shaker et al., 
2008), prebiotics (Quintero et al., 2011) and essential oils derived from plants (Amalaradjou 
et al., 2009; Amalaradjou and Venkitanarayanan, 2011) have been reported. Acidification of 
PIF or weaning food has been a popular strategy since the first half of 20
th
 century as a 
treatment for infant intestinal disease and chronic diarrhoea (Carrion and Egan, 1990). Both 
chemically and biologically acidified formula have been reported to be effective in limiting 
bacterial proliferation and/or the consequent infection disease in in vitro and in vivo studies 
(Back et al., 2009; Boneti et al., 2009; Brunser et al., 1989; Carrion and Egan, 1990; Joosten 
and Lardeau; 2004; Mehall et al., 2001; Mehall et al., 2002; Nout et al., 1989). On the other 
hand, the downsides of these approaches like systemic infection caused by some probiotic 
strains and acidosis caused by HCl have been documented in infant receiving acidified 
formulae (Boneti et al., 2009; Carrion and Egan, 1990; Mehall, et al., 2002). Additionally, a 
high proportion of children who rejected the commercial biologically acidified infant 
formula (pH 4.8) due to the taste have been reported by Brunser et al. (1989). In the present 
work the physiological gastric acidity was taken into consideration for the first time. In the 
experimental model simulating the infant gastric condition, infant formula mildly acidified 
with acetic acid to pH 6.0 showed a significant antibacterial effect against Cronobacter 
combined with natural physiological acidity of pH 5.0. Compared to acidification 
interventions previously reported with pH values ranging from < 4.0 to 5.0, the current 
CHAPTER 6 
 
68 
 
intervention with a higher pH has a lesser impact of taste. A better sensorial acceptance and 
a higher tolerance of the diet are to be expected, whilst the antimicrobial activity is 
preserved (Chapter 3). 
   
The actual pH in infant intestinal lumen is substantially influenced by food intake. 
McClendon et al. (1917) reported pH 3.1 and 6 in infant duodenal and ileum contents 
respectively. In a clinical study performed by Senger et al. (1987), the pH values in 
duodenal juice of infants ranged approximately between 5.5 and 6.5. It thus raises the 
question whether the beneficial effects of acid-treated PIF reported in the present work still 
exist in the intestinal lumen, once the acidified product is neutralised in the small intestines. 
Short-chain fatty acids (SCFAs) including acetic, propionic and butyric acid have been 
reported to be produced quantitatively in intestinal regions of both breast-fed and bottle-fed 
neonates due to gut microbial fermentation of prebiotic substances such as human milk 
oligosaccharides or GOS/FOS supplemented in infant formulation (Roberfroid et al., 2010). 
The presence of SCFA lowers the pH and might exert synergic antimicrobial effect in 
intestinal lumen after acidified PIF is ingested. Siigur et al. (1993) showed differences on 
SCFA pattern between formula feeding and breast feeding. At age of two months, the 
breast-fed infants had a significantly higher proportion of acetic acid in the SCFA spectra 
than the bottle-fed infants. Whereas acetic acid is the dominant SCFA produced by 
Bifidobacterium, Bacterioides and Clostridium produce a variety of other SCFAs e.g. 
butyric, propionic, formic and lactic acids in addition to acetic acid (Madigan et al., 2010). 
As shown by Back et al. (2009) as well as in Chapter 3, the bactericidal effect against 
Cronobacter spp. varies between organic acids. Therefore further investigation on additional 
contribution of SFCA to growth inhibition of Cronobacter in acidified or non-acidified PIF 
in intestinal lumen as well as in vivo tests of feeding tolerance and sensory acceptance 
would be beneficial.  
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6.2 Improvement of the Screening Procedure for the 
Cronobacter Detection from PIF  
Most published methods included a pre-enrichment step, a selective enrichment broth and 
plating on chromogenic agars. A pre-enrichment step is essential in enabling detection of 
target micro-organisms in low levels, as it can promote the bacterial multiplication from a 
single cell to levels of > 10
3
 CFU/ml in the enrichment broth (Kandhai, 2010). A 
pre-enrichment step is necessary for the recovery of injured or stressed cells which were 
exposed to chemical or physical treatments during the food processing (Van Schothorst, 
1976). Selective media have been shown not suitable to be applied in the initial enrichment 
step due to their poor ability to recover stressed cells (Chen et al., 2010). Chen et al. (2010) 
evaluated three enrichment broths BPW, BHI and EE for their recovery of healthy as well as 
heat- and desiccation-stressed Cronobacter in PIF and concluded BPW as most sufficient 
for recovering target micro-organisms.  
 
The selective enrichment step aims at providing the specific growth condition of the target 
micro-organisms via promoting their growth while inhibiting other background micro-flora 
to the greatest extent. The mLST broth recommended in the standard ISO method ISO/TS 
22964:2006 modifies the protocol of Guillaume-Gentil et al. (2005) by adding 0.5 M NaCl 
against competing non-Cronobacter Enterobacteriaceae and the vancomycin against 
gram-positive micro-organisms. To enhance the selectivity, a relatively high incubation 
temperature (44°C ± 0.5°C) was applied. The U.S. FDA-recommended method 
(Anonymous, 2002) proposed EE broth as the screening enrichment, a medium which was 
designed for isolation of the total Enterobacteriaceae strains. It has been reported that the EE 
broth was not selective enough as it could allow other Enterobacteriaceae to outgrow 
Cronobacter and give false negative results (Iversen et al., 2004a). In a comparative study of 
Iversen and Forsythe (2007), mLST has been evaluated as more selective than other three 
selective media including EE, Enterobacter sakazakii selective broth (ESSB) and 
Enterobacter sakazakii enrichment broth (ESE) which replaced dextrose and/or lactose with 
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sucrose. On the other hand, however, it has been established that there are Cronobacter 
isolates unable to grow in mLST or brilliant green bile broth or do not grow at an elevated 
temperature of 44°C (Iversen et al., 2007b; Iversen and Forsythe, 2007; Joosten et al., 2008). 
In this respect, improvements in detection methods for Cronobacter have been focused on 
the optimization of selective enrichment media. A new protocol using a Cronobacter 
screening broth (CSB) which enables the growth of Cronobacter strains sensitive to EE and 
mLST broths has been developed (Iversen et al., 2008a). Both this new protocol and the ISO 
standard method showed equally high sensitivity and specificity for testing Cronobacter spp. 
from PIF end products, raw materials and environmental samples. One of the greatest 
advantages of using the CSB screening method is that a release decision on Cronobacter 
negative sample can be made within 48 h. To confirm a positive result, all protocols reported 
to date require still up to 5 to 6 days (Table 2). 
 
The practicability and feasibility of a rapid impedance method with complementary 
molecular-based confirmation system for Cronobacter detection in PIF samples were 
explored in Chapter 4. This new protocol involves a pre-enrichment step in BPW for 16 h, 
which allowed the full growth of a healthy C. sakazakii strain in 100 g PIF reconstituted in 
900 ml BPW from an initial level of 1 CFU to approximately 10
8
 CFU. Injured cells might 
have a prolonged lag time and this may add several hours to the overall detection time. With 
this new protocol, heat and desiccation-injured C. sakazakii strains were recovered 
successfully within a short DT as well. Kandhai et al. (2006) reported that different 
pre-culturing conditions exhibited no effect on either lag time or growth rate of Cronobacter 
spp. and concluded that the rich growth medium, the reconstituted PIF, may be responsible 
for not measuring differences. The lag time for desiccated cells to recover after PIF 
rehydration at 37°C has been estimated to be 1.73 ± 0.44 h (Kandhai et al., 2006). The 
doubling time of 20 min at 37°C for Cronobacter has been reported by Iversen et al. (2004b). 
Theoretically, stressed Cronobacter cells present initially at 10
2
 CFU/100 g sterile PIF 
sample would well multiply to exceed a final concentration of 10
8
 CFU/ml within a 16 h 
incubation time in BPW. In the impedance devices, the signal for a successful bacterial 
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detection is given only when the target micro-organisms have increased to at least 10
6
-10
7
 
CFU/ml (Firstenberg-Eden, 1984). A bacterial density of approximately 10
6
 CFU/ml would 
be reached for both the healthy and stressed cells if 0.1 ml aliquot is transferred from 
pre-enrichment into the impedance measuring cells giving an explanation of short DTs < 1-2 
h obtained for most of the target micro-organisms handled in the present work.  
 
In the current new protocol, BiMedia 144A is a coliform selective media that has been 
adapted to enable the growth of laurylsulfate– and/or crystal violet sensitive Cronobacter 
strains. Despite the addition of vancomycin and the relatively enhanced incubation 
temperature of 42°C, the selective nature of the BiMedia 144A is limited, as it allows well 
the growth of non-Cronobacter Enterobacteriaceae competitors. As a result, BiMedia 144A 
remains a screening tool in the current protocol and has to be used complementary with 
confirmation systems like RiboFlow
TM
 or any agar medium. The overall effectiveness of the 
method is therefore dependent on the sensitivity and specificity of the confirmation assay 
used. In the present study, the 16S rRNA-based RiboFlow
TM 
identification system has been 
shown to be 100% sensitive and specific to Cronobacter species. For this assay a minimum 
population for Cronobacter spp. of 10
5
 CFU/ml is required to obtain a positive signal 
(personal communication). The new protocol described in Chapter 4 was not capable of 
covering sensitive Cronobacter strains CLF2684 and CLF248 in the presence of rapidly 
growing Enterobacteriaceae strains E. cloacae and C. freundii in 15 of 32 (47%) cases. 
These false negative results are probably due to the reduced growth rate of Cronobacter spp. 
in the pre-enrichment broth and/or selective enrichment broth BiMedia 144A caused by the 
interference of competing micro-flora which might prevent the target micro-organism from 
multiplying to a minimum cell concentration needed for a positive confirmation.  
 
Based on data of artificially spiked PIF experiments, the impedance-RiboFlow
TM
 protocol 
exhibited an overall higher sensitivity (85%) and specificity (100%) for detection of 
Cronobacter compared with the reference procedure comprising pre-enrichment in BPW, 
selective enrichment in mLST and isolation on DFI agar. With the employment of the 
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impedance method, the maximally incubation time in impedance media was shortened to 13 
h. Samples by which the M-value of 5% is surpassed with DT > 13 h are negative for 
Cronobacter and the release decision can thus be made 29 h after start of sample 
pre-enrichment; also, the work and cost outlays are substantially reduced, as only samples 
with DT < 13 h need to be further confirmed.  
 
As mentioned in Chapter 1, high numbers of complex competing flora contained in raw 
ingredients as well as antimicrobial substances in special infant formulae may reduce the 
growth rate of Cronobacter spp. in the pre-enrichment and hence lead to a false negative 
outcome by detection. Table 1 showed the results of follow-up tests of detection of 
Cronobacter from artificially spiked raw ingredients and fermented infant formulae (FIF) 
using the impedance-RiboFlow™ method and the reference method identical to that 
described in Chapter 4. Fewer samples were found positive for Cronobacter when using 
reference method than when using impedance-RiboFlow™: While Cronobacter was 
recoverable by both means in maltodextrin, RiboFlow™ recovered the target strains from 
100% (3/3) and reference method from 66% (2/3) of the thickening agent samples. For three 
maize meal samples from which endogenous K. pneumoniae was isolated, the target strain 
was not detected by both methods, yet the sensitivity of the impedance-RiboFlow™ being 
slightly higher than that of reference method. In two spiked FIF products, Cronobacter spp. 
were successfully recovered by both impedance-RiboFlow
TM 
and the reference procedure. 
Significantly prolonged DTs exceeding 7 h were obtained for FIF product Gallia Lactofidus 
which achieved a pH value of 5.0 after fermentation, indicating that the growth of C. 
sakazakii was slowed down in the pre-enrichment in reconstituted product probably due to 
the relatively lower pH value and the inhibition of bioactive substances emerging after 
product fermentation. 
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Table 1. Detection of C. sakazakii CLF2688 (10
0–101 CFU/100 g) from raw ingredients and 
fermented infant formulae 
 
 Impedance DT (h)
a
  Impedance-RiboFlow™  mLST-DFI 
Maltodextrin 1.64 +  + 
 1.51 +  + 
 1.06 +  + 
Xanthan gum 1.67 +  - 
 1.59 +  + 
 1.54 +  + 
Maize meal 1.27 +  - 
 1.14 -  - 
 1.38 -  - 
Gallia Calisma 1.07 +  + 
 1.44 +  + 
 1.88 +  + 
Gallia Lactofidus 7.81 +  + 
 8.70 +  + 
 7.93 +  + 
a
 The results of triplicate tests are shown for each of three raw materials and two fermented infant formulae. 
 
More recently, the FDA method has been revised to incorporate a slightly modified form of 
the real time PCR assay developed by Seo and Brackett (2005) and two chromogenic agars 
for Cronobacter detection from PIF. The revised FDA method has been proved to shorten 
the analysis time substantially and to increase the sensitivity and specificity as compared to 
the original FDA protocol (Chen et al., 2010). As reported by Fanning and Forsythe (2008), 
a pre-enrichment procedure is necessary to increase the population to 10
2
 CFU/ml to meet 
the detection limit of PCR. When serving as a screening tool in the revised FDA protocol, 
the real time PCR assay showed a higher detection limit: a population of target 
micro-organism of 10
3 
CFU/ml in the pre-enrichment step in BPW is required to enable 
successful detection of Cronobacter in PIF contaminated with natural background flora in 
low amounts, while for recovering target micro-organism with a strong interference of 
background flora such Samonella and E. cloacae in PIF, a population of 10
5 
CFU/ml is 
necessary (Chen et al., 2010). One limitation of PCR analysis is that DNA from dead cells 
can be amplified, resulting in false-positive outcomes. Another disadvantage using 
molecular based detection technologies is that the micro-organism itself cannot be isolated 
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and studied further. Furthermore, matrix interference on PCR assay has been reported 
(Wilson, 1997). Therefore, in the revised FDA method, the PCR analysis utilized as 
screening tool must be followed by a subsequent culture-based confirmation step.  
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6.3 Chromogenic Isolation Media and Identification 
Systems for the Detection of Cronobacter  
As discussed above, none of the selective enrichment broths developed so far is able to 
support the growth of all currently known Cronobacter phenotypes and ensures at the same 
time a high selectivity. Therefore an isolation step of streaking the selective enrichment 
broth onto selective solid media is incorporated in the conventional procedure after the 
selective enrichment stage. Being used as the primary isolation agar in the FDA method 
(Anonymous, 2002), the VRBGA is selective only for Enterobacteriaceae and coliforms and 
is not specific for Cronobacter due to its limited screening property for only one differential 
characteristic (acid production from glucose). On VRBGA, Cronobacter spp. and all other 
enteric bacteria can produce red-pink colonies (Iversen and Forsythe, 2007; Restaino et al., 
2006). The chance of isolating of Cronobacter spp. colony from VRBGA is thus highly 
dependent on the numbers of competing enteric bacteria grown on it. Based on the unique 
feature of α-glucosidase activity of Cronobacter spp., several chromogenic media have been 
developed to differentiate Cronobacter spp. from other members of Enterobacteriaceae. DFI 
agar which makes use of two differential characteristics, X-α-D-glucopyranoside and 
hydrogen sulphide production, showed a 100% sensitivity for Cronobacter spp. yielding 
typical blue-green colonies and a specificity of 87.2% at 37°C, producing false positive 
results on certain Pantoea spp., C. koseri and Escherichia vulneris strains (Iversen et al., 
2004a). The ISO/TS 22964 (Anonymous, 2006b) proposed the use of ESIA agar for 
Cronobacter isolation with an incubation temperature of 44°C. Though an excellent 
specificity of ESIA was demonstrated in several studies, reduction in its sensitivity has been 
determined as some Cronobacter strains were inhibited by crystal violet as the medium 
component and by the high incubation temperature of 44°C (Iversen and Forsythe, 2007; 
Iversen et al., 2007b). The inclusion of two chromogenic substrates X-α-D-glucopyranoside 
and X-β-D-cellobioside, three sugars, a pH indicator and inhibitors like bile salts, cefsulodin 
and vancomycin in the ESPM agar was therefore intended to improve the sensitivity and 
selectivity of this new medium for Cronobacter spp. (Restaino et al., 2006). Compared with 
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the FDA procedure which involves VRBG and TSA, a greater number of Cronobacter spp. 
were recovered from a variety of food and environmental sources using ESPM with a higher 
sensitivity and specificity (Restaino et al., 2006). Iversen et al. (2007b) compared the 
efficacy of ESIA, ESPM and DFI on 210 target and 102 non-target strains at recommended 
temperatures and found 3.8% of Cronobacter strains grew but did not produce 
blue-green-pigmented colonies on DFI due to the weak α-glucosidase activity. To enable the 
production of typical blue-green colonies, the concentration of X-α-D-glucopyranoside was 
increased by 50%. The modified DFI showed the highest sensitivity of 100%, followed by 
ESPM (99.5%). In the comparative test in the present work (s. Addendum), ChromoCult
TM
 
showed the highest specificity with only one non-Cronobacter strain CLF2685 Enterobacter 
pulveris producing typical colonies on it. On the other hand, the sensitivity of 
ChromoCult
TM
 agar (92%) was lower than other media tested due to the misidentification of 
C. malonaticus CLF2689. All the other five chromogenic media showed a sensitivity of 
100%, while the specificity varied from 44% for DFI to 67% for Compass and ESPM. 
 
In a study of Lehner et al. (2006), twelve strains isolated from fruit powder produced 
presumptive colonies on DFI and ESIA. However, data of 16S rRNA gene sequencing and 
ribotyping analysis clearly revealed that they did not belong to the group Cronobacter spp. 
To distinguish these questionable, unclassified members of Enterobacteriaceae from 
Cronobacter spp., Stephan et al. (2007, 2008) performed a taxonomic polyphasic study and 
proposed a new taxonomic assignment for these strains of the genus Enterobacter as E. 
helveticus, E. turicensis and E. pulveris. Isolates of the three novel Enterobacter species 
have been found in the same ecological inhabitants as Cronobacter spp. such as infant 
formula, dried food products and infant formula processing environments (Stephan et al., 
2007; Stephan et al., 2008). Sharing typical characteristics with Cronobacter spp. e.g. 
production of yellow pigment and hydrolysis of XαGlc and 4NPαGlc due to α-glucosidase 
activity, E. helveticus, E. turicensis and E. pulveris have been determined to present as the 
main false positive presumptive organisms on chromogenic media containing XαGlc like 
ESIA, DFI or ESPM and to pose a challenge for isolation methods of Cronobacter 
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(Addendum, Iversen et al., 2007b; Lehner et al., 2006). 
 
The presence of typical colony morphologies on isolation agar is only a presumptive 
identification. A confirmation step is needed. Among a variety of identification systems, 
commercially available biochemical galleries based on phenotypic characteristics such as 
API 20E, ID 32E, Biolog etc. are still preferably used in the laboratories for Cronobacter 
identification due to the simple performance and low costs. Iversen et al. (2004a) assessed 
two commercial tests kits, FDA recommended-API 20E and ISO/TS 26994 
recommended-ID 32E, and reported apparent disagreement between them in the efficacy of 
identification of Cronobacter spp.: of 12 strains identified as Pantoea spp. strains using API 
20E, ten had higher levels of confidence as Cronobacter spp. (E. sakazakii) using the ID 
32E panel. The limited number of tests included in the API 20E test kit e.g. the lack of 
α-glucosidase reaction might be responsible for its inadequacy in identifying Cronobacter. 
Further studies of Iversen et al. (2007b) showed that ID 32E was more reliable than API 20E 
for Cronobacter identification, with 99.5% of the Cronobacter strains correctly identified, 
while the API 20E gallery was only 70% successful for identifying the target strains. On the 
other hand, Fanning and Forsythe (2008) reported a higher sensitivity and specificity of 
Biolog GN2 than ID 32E and API 20E. For the three novel Enterobacter species, the ID 32E 
test performed by Lehner et al. (2006) suggested ambiguous identification results as E. 
vulneris, Pantoea spp. and Buttiauxiella agrestis. In the study of Iversen et al. (2007b), no 
false positive identifications as Cronobacter spp. were obtained on these three species by 
using ID 32E gallery. As shown in Table 1 Chapter 5, an isolate of E. pulveris was identified 
as Cronobacter spp., however, with a low level of confidence using ID 32E. Other kits 
including Rapid ID 32E have been reported to give equally variable results e.g. with 
misidentification of E. pulveris as Cronobacter spp. (Druggan and Iversen, 2009). Due to 
the inter- and intra-species biochemical heterogeneity and the instable expression of 
phenotypic features of Cronobacter and related organisms, none of the commercially 
available biochemical kits showed an accuracy of 100% for Cronobacter identification. In 
this respect, Restaino et al. (2006) suggested that the Cronobacter identification should be 
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based on more than one identification system. Notably, none of the databases of these 
commercial biochemical kits have been updated with the 2007 taxonomic revisions and the 
discrimination is limited at the Cronobacter genus level.  
 
It is known that α-glucosidase is a characteristic feature for Cronobacter species. Depending 
on the α-glucosidase substrate, different profiles can be generated (Iversen et al., 2007b). 
The fermentation of XαGlc is e.g. typical for the α-glucosidase activity of all Cronobacter 
species. Hydrolysis of α-methyl-D-glucoside (αMGlc) is a further test of α-glucosidase. All 
Cronobacter spp. except for one species C. muytjensii can ferment this substrate. 
Interestingly, E. helveticus, E. turicensis and E. pulveris are positive for hydrolysis of XαGlc 
and are therefore the main false positive organisms on chromogenic media containing 
XαGlc, but they can not ferment αMGlc. It would appear that using a combination of 
α-glucosidase substrates might facilitate a more accurate identification of presumptive 
Cronobacter spp. (Druggan and Iversen, 2009).  
 
Compared to phenotypic methods, molecular-based techniques have been increasingly used 
because they usually enable a more sensitive, more specific and more rapid identification of 
Cronobacter. To date two molecular-based methods, the α-glucosidase (gluA) PCR and the 
real time PCR assay targeting the dnaG gene encoding the DNA-primase have been broadly 
evaluated on an extensive collection of target and non-target strains. In most cases, both 
systems have proven to be 100% sensitive and specific for Cronobacter spp. (Drudy et al., 
2006; Iversen et al., 2007b; Lehner et al., 2006). The only exception was shown on a type 
strain of E. turicensis (LMG 23730) where a false positive result was obtained using the real 
time PCR protocol targeting dnaG gene (Lampel and Chen, 2009). In a comparative 
evaluation of several commercially available real time PCR-based systems for Cronobacter 
identification, the Assurance GDS
TM
 Enterobacter sakazakii and the foodproof
®
 
Enterobacter sakazakii Detection Kit were 100% successful for differentiating Cronobacter 
spp. from other Enterobacteriaceae strains including E. helveticus, E. pulveris and E. 
turicensis (Fricker-Feer et al., 2011). Similarly, a high accuracy of 100% of the foodproof
®
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Enterobacter sakazakii Detection Kit for Cronobacter identification has been shown in the 
present work (s. Addendum). In the study of Lehner et al. (2006), twelve non-Cronobacter 
strains isolated from fruit powder reliably identified using 16S rRNA gene analysis were 
correctly identified as negative for Cronobacter with α-glucosidase PCR, although they 
produced typical colonies on ESIA and DFI. In the subsequent investigations performed by 
Stephan et al. (2007; 2008), it has been proposed that these isolates represent novel 
Enterobacter species E. pulveris, E. turicensis and E. helveticus. The results suggest 
strongly that the α-glucosidase PCR system exclusively target the gene encoding the 
α-glucosidase in Cronobacter spp. Furthermore, in the same study of Lehner et al. (2006), a 
100% sensitivity and specificity for Cronobacter spp. was shown on the 16S r RNA-based 
FISH assay VIT
®
 as well.   
 
The PCR-based technique requires a step of DNA extraction prior to amplification set up 
and is thus restricted to especially equipped laboratory. Results are obtained within 4 h when 
using PCR for Cronobacter identification. The commercial FISH kit VIT
® 
and RiboFlow
TM
 
assay are based on fluorescently labelled gene probes targeting special regions of 16S rRNA 
of the bacteria, therefore only vital Cronobacter cells containing a high ribosomal content 
are detected by the systems. Both kits are easy and convenient to handle. Especially the 
detection time required by RiboFlow
TM 
is substantially decreased to 15 min. As shown in the 
study of Lehner et al. (2006) as well as in Chapter 5 and in Addendum, they performed 
equally well in identifying Cronobacter spp. with a high sensitivity and specificity.  
 
All the above-mentioned methods facilitate an identification of Cronobacter spp. only at 
genus level. Using polyphasic methods including f-AFLP fingerprints, ribopatterns and 
full-length 16S rRNA gene sequences, a set of 210 E. sakazakii (Cronobacter) strains have 
been divided into separate groups and a reclassification of these organisms as Cronobacter 
on the genus level containing eight (sub-) species has been proposed (Iversen et al., 2007a; 
Iversen et al., 2008b). In the present work in which totally 22 target and non-target strains 
were tested, Cronobacter strains were 100% assigned to species level and were successfully 
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separated from closely related Enterobacteriaceae strains using 16S rRNA gene sequencing 
(Chapter 5). A distinguishment between C. sakazakii and C. malonaticus was not possible 
due to the high similarity of their 16S rRNA gene sequences. The restricted discriminatory 
power for Enterobacteriaceae reported by Drancourt et al. (2000) and Lehner and Stephan 
(2004) has been demonstrated on three of non-target strains, for which ambiguous 
identifications were suggested (Table 2 Chapter 5). Overall the 16S rRNA gene sequencing 
is regarded as a superior identification tool compared to phenotypic methods due to the 
stability of the genome over time, high reproducibility and resistance to external influences 
rapidity and robust read-out (Clarridge, 2004; Sauer and Kliem, 2010). Providing 
phylogenetically meaningful information, it has been used in several studies as adjunct to 
phenotypic methods for the identification of difficult-to-identify bacteria or as reference 
standard to evaluate the accuracy of phenotypic identification systems (Bosshard, et al., 
2006; Fanning and Forsythe, 2008; Iversen et al., 2007c, Lehner et al., 2006). On the other 
hand, some well-known limitations of 16S rRNA gene sequencing have been listed. Firstly, 
the quality of the sequence is critical and undetermined positions > 1% can interfere with the 
interpretation (Clarridge, 2004; Drancourt et al., 2000). Secondly, although the sequence 
itself is objective, the interpretation of data is subjective and no universally acceptable 
guideline of 16S rRNA sequence similarity for bacterial designation is available so far. A 
97% similarity was previously proposed for species delineation (Stackebrandt and Goebel, 
1994); nevertheless, a cut-off value ranging between 98.7-99.5% has been recently amended 
(Palys et al., 1997). Thirdly the interpretation of sequences highly depends on the quality of 
the database. The quality of public database has been questioned because of lack of peer 
review (Boudewijns et al., 2006; Mignard and Flandrois, 2006). On the other hand, the 
commercial database of a better quality with more correct sequence entries might have the 
disadvantage of limited number of sequences and the enhanced cost of analysis (Clarridge, 
2004).  
 
MALDI-TOF MS has become a convenient tool for bacterial identification due to its 
promising advantages e. g. rapidity, high-throughput, simple sample preparation, ability to 
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detect minor differences between strains and direct comparison between 
strains-characteristic patterns (Holland et al., 1996; Rupf et al., 2005; Stephan et al., 2010; 
Wang et al., 1998). Stephan et al. (2010) were the first to describe the identification of 
Cronobacter with MALDI-TOF MS technique with development of a reference mass 
spectrometry library based on 54 Cronobacter strains and 17 Enterobacter species. With the 
same database, all Cronobacter species and non-Cronobacter species including 
phenotypically similar E. helveticus, E. turicensis and E. pulveris were unambiguously 
identified using MALDI-TOF MS with a high accuracy of 100% in the present work 
(Chapter 5). Moreover, instead of using pure cultures, Javůrková et al. (2012) spiked PIF 
products artificially with Cronobacter species and identified them correctly at genus level 
using MALDI BioTyper
TM
 system (Bruker Daltonics, Germany). More recently, the 
potential of rapid taxonomic resolution for Cronobacter using MALDI-TOF MS has been 
expanded at biogroup level. Karamonová et al. (2012) created a protein peak pattern 
database for eight biogroups of C. sakazakii proposed by Iversen et al. (2008b) by analyzing 
300 spectra of 19 C. sakazakii reference strains and 5 non-Cronobacter Enterobacter strains 
as negative controls. The validity of this protocol based on biogroup-specific patterns was 
successfully confirmed by using another ten non-identified strains and the results obtained 
using MALDI-TOF MS were in accordance with that using a series of reference 
biochemical tests. On the other hand, Cetinkaya et al. (2013) reported discrepancy on two 
Cronobacter isolates at species level between MALDI-TOF MS and 16S rRNA gene 
sequencing. It has been reported that peak patterns generated by mass spectrometry 
measurement may vary strongly with various culture and sample preparation conditions like 
growth time, cultivation media, solvent condition and extraction method, thereby affecting 
the identification result of MALDI-TOF MS (Wang et al., 1998). The results were more 
reproducible and the peaks were generated in a higher intensity and higher number by 
incubation on TSA for 48 h than on Brain Hearth Infusion Agar (BHA), Blood Agar and 
ESIA for 24 h (Karamonová et al., 2012; Stephan et al., 2010). Therefore to guarantee the 
accuracy and stability, it is paramount to standardize the sample preparation and incubation 
procedures. Importantly, the protein mass peaks represent complex and variable fingerprints 
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of peptides and small proteins extracted from the whole cell and the m/z value alone is not 
sufficient to allow an assignment of individual peaks to special molecules (Rupf et al., 2005). 
Identification of bacteria based on specific biomarkers should rely on known peptides, 
which indicates the importance of identifying unique conserved biomarkers instead of only 
observing spectral pattern difference for bacterial identification and differentiation (Wang et 
al., 1998). Limited database entries for specific proteins and peptides can be a crucial factor 
for incorrect bacterial identification with MALDI-TOF MS. 
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Summary 
Contaminated powered infant formula (PIF) has been identified to be linked with a number 
of clinical outbreaks of rare but life-threatening infections in infants associated with 
Cronobacter. The overall objective of this thesis is to evaluate the impact of 
microbiologically active substances in PIF on the growth and detection of Cronobacter spp. 
Depending on preparation, storage and feeding practices, a potential rapid growth of 
Cronobacter spp. in reconstituted PIF is possible. The first aim was to investigate the 
effectiveness of using hot water of 70°C or higher on inactivation of Cronobacter spp. 
during PIF rehydration. It was showed that PIF reconstituted with water of 80°C in plastic 
bottle caused a cell reduction of Cronobacter spp. of greater than 3 log and this might thus 
reduce substantially the risk of infection in infants. Although the effect of fermented infant 
formula (FIF) on suppression of Cronobacter spp. growth was shown to be partially offset 
by water of 80°C, this inhibitive effect based on the bioactive substances emerging after 
infant formula fermentation was not strong enough. It was assumed that a direct 
reconstitution of FIF with water of 80°C may lead to a greater inactivation of Cronobacter 
spp. and result in a reduction of potential infection risk in higher magnitude.  
 
Incorporation of organic acids in PIF contributes to an alternative in controlling 
Cronobacter growth in rehydrated PIF. The present study first reported the synergistic effect 
of combination of infant formula moderately acidified with organic acid to pH 6.0 and 
physiological infant gastric acidity of pH 5.0: Under the simulated neonatal gastric acid 
condition, the slightly acidified infant formula which did not show inhibitive effect solely 
reduced significantly the Cronobacter population. Compared with other acidification 
interventions reported to date where a low pH of ≤ 5.0 was achieved, the acidified formula 
presented in this work is expected to improve the taste due to the natural pH value and yet 
preserve the bacteriostatic activity. 
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Microbiologically active substances present in infant formula product such competitive flora 
and/or antimicrobial components can inhibit the growth of Cronobacter and further affect 
the effectiveness of the detection method for Cronobacter. A new protocol for rapid 
detection of Cronobacter spp. from PIF and raw materials using impedance method 
combined with rRNA-based lateral flow assay has been evaluated, particularly on 
products/matrices with high amounts of competing background flora and on inhibitive 
specialised infant formulae. Compared with the reference method based on ISO/TS 22964, a 
higher sensitivity and specificity were observed, and the detection time was substantially 
reduced to 29 hours to obtain a final confirmation for Cronobacter in this new protocol 
whereas the standard protocol needs 6 days.  
 
The present work has also represented a comparative assessment of various systems 
including chromogenic agars, FISH, real time PCR, 16S rRNA gene sequencing, API and 
MALDI-TOF MS for the detection and identification of Cronobacter spp.. While the 
phenotypic systems based on biochemical reactions gave false positive or false negative 
outcomes for Cronobacter spp., the molecular-based identification systems have shown an 
accuracy of 100% in differentiating Cronobacter from non-Cronobacter strains. Both 16S 
rRNA gene sequencing and MALDI-TOF MS assigned isolates to species level, but the 
identification of MALDI-TOF MS was more discriminating and unambiguous, with results 
provided more rapidly within a few minutes.  
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Zusammenfassung 
Cronobacter verursacht bakterielle Infektionen mit nekrotisierenden Enterokolitiden, 
Meningitiden und Septikämien bei Neu- und Frühgeborenen, deren Ursprung in Verbindung 
mit kontaminierter Säuglingsnahrung gebracht wird. Ziel dieser Arbeit war es 
Nachweismethoden für Cronobacter zu vergleichen, um ein möglichst schnelles und 
sicheres Nachweissystem zu entwickeln. Darüber hinaus sollten Substanzen identifiziert 
werden, die das Wachstum von Cronobacter in der Säuglingsmilchnahrung reduzieren. Der 
Einfluß der Zubreitung, Lagerung und Handhabung der gefertigten Milchnahrung auf das 
Wachstum von Cronobacter wurde untersucht. Zunächst wurde Wasser mit einer Temperatur 
von 70°C oder höher zur Rekonstituierung der Trockenmilch verwendet und die 
Überlebensrate von  Cronobacter geprüft. Die Ergebnisse zeigten, dass sich die Keimzahl 
von Cronobacter in Säuglingsnahrung, welche mit 80°C heißem Wasser in Babyflaschen 
aus Kunststoff zubereitet wurde, um mindestens drei Zehnerpotenzen verringerte. Somit 
könnte das Infektionsrisiko von Cronobacter durch die Verwendung von 80°C heißem 
Wasser und Kunststoffflaschen erheblich reduziert werden. Auch die mit 40°C warmen 
Wasser zubereitete fermentierte Säuglingsnahrung zeigte leicht reduziertes Wachstum von 
Cronobacter. Allerdings ist dieser Hemmungseffekt, der auf die nach der Fermentierung 
aufgetauchten bioaktiven Substanzen zurückzuführen ist, nicht stark genug. Es wird 
vermutet, dass eine Rekonstituierung der fermentierten Säuglingsnahrung mit 80°C heißem 
Wasser direkt zu einer stärkeren Verringerung der Keimzahl von Cronobacter führen und 
demzufolge das Infektionsrisiko im höheren Maße reduzieren könnte.  
 
Die Supplementierung von organischen Säuren in Säuglingsnahrung stellt somit eine Option 
zur Limitierung des Wachstums von Cronobacter in rekonstitutierter Säuglingsnahrung dar. 
Die vorliegende Arbeit ist die erste Studie, die einen synergistischen pH-Effekt zur 
Wachstumshemmung von Cronobacter beschreibt, der durch die Zugabe von organische 
Säure zur Säuglingsnahrung auf einem pH-Wert von 6,0 und der physiologischen Azidität 
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von pH 5,0 im Säuglingsmagen berichtete. In dem simulierten Model der 
Säuglingsmagensäure wurde eine eindeutige Hemmwirkung gegen Cronobacter durch diese 
leicht angesäuerte Säuglingsnahrung gezeigt, die aber keine vollständige Inhibierung gegen 
das Wachstum von Cronobacter ermöglicht. Im Vergleich zu anderen 
Ansäuerungsinterventionen, bei denen die pH-Werte unter 5,0 erreicht wurden, ist bei der 
angesäuerten Säuglingsnahrung in der vorliegenden Arbeit eine Optimierung des 
sensorischen Geschmacks gleichzeitig ohne Verlust der Wachstumshemmung zu erwarten. 
  
Mikrobiologisch aktive Substanzen in Säuglingsnahrung, zu denen auch die kompetitive 
Begleitflora und antimikrobielle Komponente gehören, können das Wachstum von 
Cronobacter inhibieren aber zudem die Effektivität der Nachweismethoden für Cronobacter 
beeinträchtigen. In diesem Zusammenhang wurde eine neue Methode zum Schnellnachweis 
von Cronobacter mittels Impedanz-Verfahren gekoppelt mit rRNA Lateral Flow Assay 
etabliert, insbesondere mit Produkten und Rohmaterialen mit einer hohen Anzahl von 
Begleitflora sowie  mit speziellen Säuglingsnahrungen mit Hemmeffekt. Gegenüber der 
standardisierten konventionellen Methode ISO/TS 22964 zeigte die neue Methode in dieser 
Arbeit eine höhere Sensitivität und Selektivität. Bei dem neuen Testverfahren ließ sich die 
gesamte Dauer wesentlich auf 29 Stunden verkürzen, während die klassische Methode sechs 
Tage brauchte, bis ein Bestätigungsergebnis für diejenige Probe, die verdächtigt positiv für 
Cronobacter war, vorlag. 
 
In dieser Arbeit wurden vielfältige Isolate, die zum Genus Cronobacter sowie zur 
nicht-Cronobacter Enterobacteriaceae-Familie gehören, vergleichend mit verschiedenen 
Testsystemen einschließlich chromogener Media, Fluorescenz in situ Hydridisierung (FISH), 
real time PCR, 16S rRNA Gensequenzierung, API und MALDI-TOF MS analysiert. 
Während die phänotypischen Methoden, deren Prinzipien auf biochemische Reaktionen 
basieren, falsch positive oder falsch negative Resultate für die Identifizierung der 
Cronobacter lieferten, zeigten die molekularbiologischen Identifizierungssysteme eine 
Genauigkeit von 100% in der Differenzierung zwischen Cronobacter und nicht-Cronobacter
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Isolaten. Eine Identifizierung auf Artebene war sowohl mit der 16S rRNA 
Gensequenzierung als auch mit der MALDI-TOF MS-Methode möglich. Im Vergleich zu 
16S rRNA Gensequenzierung waren die Ergebnisse, die von der MALDI-TOF MS-Methode 
geliefert wurden, diskriminierender und eindeutiger. Außerdem zeichnet sich diese neue 
Technologie durch einen hohen Durchsatz und eine Schnelligkeit für die 
Bakterienidentifizierung in wenigen Minuten aus. 
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NAME a ID 32E API Profile real time PCR FISH
Enterobacter sakazak ii (CC 208)  Enterobacter sakazakii 99.9%. T=0.92 34276767050 E.sakazakii positive
Enterobacter sakazak ii (CC 320)  Enterobacter sakazakii 99.9%. T=1.00 34276763250 E.sakazakii positive
Enterobacter sakazak ii (CC 553)  Enterobacter sakazakii 99.9%. T=1.00 34276767250 E.sakazakii positive
Enterobacter sakazak ii (CC 1549) b  Enterobacter sakazakii 97.4%. T=0.18 34276773050 EB negative
Enterobacter sakazak ii (CC 1552 )  Enterobacter sakazakii 99.9%. T=0.85 75276767050 E.sakazakii positive
Enterobacter sakazak ii (CC 2136 ) c  Enterobacter sakazakii 99.9%. T=0.71 34276563050 EB negative
Enterobacter sakazak ii (CC 2326)  Enterobacter sakazakii 99.9%. T=1.00 34276767250 E.sakazakii positive
Enterobacter sakazak ii (CC 2498)  Enterobacter sakazakii 99.9%. T=0.92  34276767050 E.sakazakii positive
Cronobacter muytjensii (CC 2682)  Enterobacter sakazakii 99.9%. T=0.58 34277767051 E.sakazakii positive
Cronobacter turicensis (CC 2683)  Enterobacter sakazakii 99.9%. T=0.45 74276767251 E.sakazakii positive
Cronobacter genomospecies (CC2684)  Enterobacter sakazakii 99.9%. T=0.53 34077767251 E.sakazakii positive
Enterobacter pulveris (CC 2685)  Enterobacter sakazakii 99.9%. T=0.28 34476773050 EB negative
Cronobacter dublinensis subsp. lausannensis (CC2687)  Enterobacter sakazakii 99.9%. T=0.75 34275763250 E.sakazakii positive
Cronobacter sakazak ii (CC 2688)  Enterobacter sakazakii 99.9%. T=1.00 34236767250 E.sakazakii positive
Cronobacter malonaticus (CC 2689)  Enterobacter sakazakii 99.9%. T=0.68 34076763251 E.sakazakii positive
Cronobacter dublinensis subsp. lactaridi (CC 2691)  Enterobacter sakazakii 99.9%. T=0.83. 34277767250 E.sakazakii positive
Enterobacter helveticus (CC 2686)  Escherichia vulneris 96.1%. T=0.25 34474561051 EB negative
Enterobacter turicensis (CC2690 )  Escherichia vulneris 83.2%. T=0.41 4474563011 EB negative
Enterobacter asburiae (CC 135)  Escherichia vulneris 98.1%. T=0.87 4474543051 EB negative
Leclercia adecarboxylata (CC 770)  Leclercia adecarboxylata  99.9%. T=1.0 4475753111 EB negative
Pantoea (CC 197)  Pantoea spp 1 99.9%. T=0.97 74703001 EB negative
Table 1. Comparison of confirmation methods for Cronobacter spp. 
 
 
 
 
 
 
a
: E. sakazakii designation according to ID 32E. 
b
 
c
: cc1549 and cc2136 were identified as E. pulveris and E. helveticus 
by 16S rRNA gene sequencing. 
 
Table 2. Sensitivity and specificity of different chromogenic Cronobacter media 
Species ESIA Compass HarlequinT ChromoCult DFI ESPM
Reference 
methods 
Cronobacter
Enterobacter sakazak ii (CC 208) + + + + + + positive
Enterobacter sakazak ii (CC 320) + + + + + + positive
Enterobacter sakazak ii (CC 553) + + + + + + positive
Enterobacter sakazak ii (CC 1552) + + + + + + positive
Enterobacter sakazak ii (CC 2326) + + + + + + positive
Enterobacter sakazak ii (CC 2498) + + + + + + positive
Cronobacter muytjensii (CC 2682) + + + + + + positive
Cronobacter turicensis (CC 2683) + + + + + + positive
Cronobacter genomospecies (CC 2684) + + + + + + positive
Cronobacter dublinensis subsp. lausannensis (CC 2687) + + + + + + positive
Cronobacter sakazak ii (CC 2688) + + + + + + positive
Cronobacter malonaticus (CC 2689) + + + - + + positive
Cronobacter dublinensis subsp. lactaridi (CC 2691) + + + + + + positive
Enterobacter pulveris (CC 2685) + + + + + - negative
Enterobacter helveticus (CC 2686) + - + - + + negative
Enterobacter turicensis (CC 2690) - - - - + + negative
Enteroacter sakazak ii (CC 1549) + + + - + - negative
Enteroacter sakazak ii (CC 2136) + + + - + + negative
Enterobacter asburiae (CC 135) - - - - - - negative
Escherichia vulneris (CC 204) - - - - - - negative
Leclercia adecarboxylata (CC 770) - - - - - - negative
Pantoea (CC 197) - - - - - - negative
Specificity against PCR/FISH as reference method 56% 67% 56% 89% 44% 67%
Sensitivity against PCR/FISH as reference method 100% 100% 100% 92% 100% 100%  
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